1
|
Sundarkumar V, Wang W, Mills M, Oh SW, Nagy Z, Reklaitis G. Developing a Modular Continuous Drug Product Manufacturing System with Real Time Quality Assurance for Producing Pharmaceutical Mini-Tablets. J Pharm Sci 2024; 113:937-947. [PMID: 37788791 PMCID: PMC10947937 DOI: 10.1016/j.xphs.2023.09.024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2023] [Revised: 09/26/2023] [Accepted: 09/28/2023] [Indexed: 10/05/2023]
Abstract
The pharmaceutical industry has shown keen interest in developing small-scale modular manufacturing systems for producing medicinal products. These systems offer agile and flexible manufacturing, and are well-suited for use in situations requiring rapid production of drugs such as pandemics and humanitarian disasters. The creation of such systems requires the development of modular facilities for making solid oral drug products. In recent years, however, the development of such facilities has seen limited progress. This study presents a development of a prototype modular system that uses drop on demand (DoD) printing to produce personalized solid oral drug products. The system's operation is demonstrated for manufacturing mini-tablets, a category of pediatric drug products, in continuous and semi-batch modes. In this process, the DoD printer is used to generate molten formulation drops that are solidified into mini-tablets. These dosages are then extracted, washed and dried in a continuous filtration and drying unit which is integrated with the printer. Process monitoring tools are also incorporated in the system to track the critical quality attributes of the product and the critical process parameters of the manufacturing operation in real time. Future areas of innovation are also proposed to improve this prototype unit and to enable the development of advanced drug manufacturing systems based on this platform.
Collapse
Affiliation(s)
- Varun Sundarkumar
- Davidson School of Chemical Engineering, Purdue University, West Lafayette, IN 47907, USA.
| | - Wanning Wang
- Davidson School of Chemical Engineering, Purdue University, West Lafayette, IN 47907, USA
| | - Madeline Mills
- Davidson School of Chemical Engineering, Purdue University, West Lafayette, IN 47907, USA
| | - Sue Wei Oh
- Davidson School of Chemical Engineering, Purdue University, West Lafayette, IN 47907, USA
| | - Zoltan Nagy
- Davidson School of Chemical Engineering, Purdue University, West Lafayette, IN 47907, USA
| | - Gintaras Reklaitis
- Davidson School of Chemical Engineering, Purdue University, West Lafayette, IN 47907, USA
| |
Collapse
|
2
|
Osmanoglu Ö, Gupta SK, Almasi A, Yagci S, Srivastava M, Araujo GHM, Nagy Z, Balkenhol J, Dandekar T. Signaling network analysis reveals fostamatinib as a potential drug to control platelet hyperactivation during SARS-CoV-2 infection. Front Immunol 2023; 14:1285345. [PMID: 38187394 PMCID: PMC10768010 DOI: 10.3389/fimmu.2023.1285345] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2023] [Accepted: 12/06/2023] [Indexed: 01/09/2024] Open
Abstract
Introduction Pro-thrombotic events are one of the prevalent causes of intensive care unit (ICU) admissions among COVID-19 patients, although the signaling events in the stimulated platelets are still unclear. Methods We conducted a comparative analysis of platelet transcriptome data from healthy donors, ICU, and non-ICU COVID-19 patients to elucidate these mechanisms. To surpass previous analyses, we constructed models of involved networks and control cascades by integrating a global human signaling network with transcriptome data. We investigated the control of platelet hyperactivation and the specific proteins involved. Results Our study revealed that control of the platelet network in ICU patients is significantly higher than in non-ICU patients. Non-ICU patients require control over fewer proteins for managing platelet hyperactivity compared to ICU patients. Identification of indispensable proteins highlighted key subnetworks, that are targetable for system control in COVID-19-related platelet hyperactivity. We scrutinized FDA-approved drugs targeting indispensable proteins and identified fostamatinib as a potent candidate for preventing thrombosis in COVID-19 patients. Discussion Our findings shed light on how SARS-CoV-2 efficiently affects host platelets by targeting indispensable and critical proteins involved in the control of platelet activity. We evaluated several drugs for specific control of platelet hyperactivity in ICU patients suffering from platelet hyperactivation. The focus of our approach is repurposing existing drugs for optimal control over the signaling network responsible for platelet hyperactivity in COVID-19 patients. Our study offers specific pharmacological recommendations, with drug prioritization tailored to the distinct network states observed in each patient condition. Interactive networks and detailed results can be accessed at https://fostamatinib.bioinfo-wuerz.eu/.
Collapse
Affiliation(s)
- Özge Osmanoglu
- Functional Genomics & Systems Biology Group, Department of Bioinformatics, Biocenter, University of Wuerzburg, Wuerzburg, Germany
| | - Shishir K. Gupta
- Evolutionary Genomics Group, Center for Computational and Theoretical Biology, University of Würzburg, Würzburg, Germany
- Institute of Botany, Heinrich Heine University, Düsseldorf, Germany
| | - Anna Almasi
- Functional Genomics & Systems Biology Group, Department of Bioinformatics, Biocenter, University of Wuerzburg, Wuerzburg, Germany
| | - Seray Yagci
- Functional Genomics & Systems Biology Group, Department of Bioinformatics, Biocenter, University of Wuerzburg, Wuerzburg, Germany
| | - Mugdha Srivastava
- Core Unit Systems Medicine, University of Wuerzburg, Wuerzburg, Germany
- Algorithmic Bioinformatics, Department of Computer Science, Heinrich Heine University, Düsseldorf, Germany
| | - Gabriel H. M. Araujo
- University Hospital Würzburg, Institute of Experimental Biomedicine, Würzburg, Germany
| | - Zoltan Nagy
- University Hospital Würzburg, Institute of Experimental Biomedicine, Würzburg, Germany
| | - Johannes Balkenhol
- Functional Genomics & Systems Biology Group, Department of Bioinformatics, Biocenter, University of Wuerzburg, Wuerzburg, Germany
- Chair of Molecular Microscopy, Rudolf Virchow Center for Integrative and Translation Bioimaging, University of Würzburg, Würzburg, Germany
| | - Thomas Dandekar
- Functional Genomics & Systems Biology Group, Department of Bioinformatics, Biocenter, University of Wuerzburg, Wuerzburg, Germany
- European Molecular Biology Laboratory (EMBL) Heidelberg, BioComputing Unit, Heidelberg, Germany
| |
Collapse
|
3
|
Sundarkumar V, Wang W, Nagy Z, Reklaitis G. Manufacturing pharmaceutical mini-tablets for pediatric patients using drop-on-demand printing. Int J Pharm 2023; 644:123355. [PMID: 37647980 PMCID: PMC10808949 DOI: 10.1016/j.ijpharm.2023.123355] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2023] [Revised: 08/22/2023] [Accepted: 08/26/2023] [Indexed: 09/01/2023]
Abstract
The pharmaceutical industry has traditionally manufactured medicines in a limited range of dose strengths, with an emphasis on addressing the needs of the largest patient subgroups. This has disadvantaged smaller patient subsets, such as children, who often cannot find drug products in dosage levels suitable for their requirements. In recent years, development of pharmaceutical mini-tablets has emerged as an attractive solution to this problem. These are small-size dosages that offer attractive features such as flexible and personalized drug dosing, ease of swallowing, and tailored drug release, making them an excellent choice for administering medicines to children. This study presents a novel technique for manufacturing pharmaceutical mini-tablets, using a drop-on-demand (DoD) printing system. In this method, a DoD system is used to generate precise droplets of a melt-based formulation, which are then captured and solidified in an inert solvent bath to produce individual mini-tablets. The study also evaluates the performance of this technique for various formulations, and quantifies two critical quality attributes (CQAs) of the resulting mini-tablets: content uniformity and dissolution behavior. The findings demonstrate that the manufactured mini-tablets can meet regulatory specifications for both CQAs, and that their release profiles can be customized by modifying the excipients used. The study also discusses promising areas of application and limitations of this technique.
Collapse
Affiliation(s)
- Varun Sundarkumar
- Davidson School of Chemical Engineering, Purdue University, West Lafayette, IN 47907, USA.
| | - Wanning Wang
- Davidson School of Chemical Engineering, Purdue University, West Lafayette, IN 47907, USA
| | - Zoltan Nagy
- Davidson School of Chemical Engineering, Purdue University, West Lafayette, IN 47907, USA
| | - Gintaras Reklaitis
- Davidson School of Chemical Engineering, Purdue University, West Lafayette, IN 47907, USA
| |
Collapse
|
4
|
Gyulai A, Körmendi J, Issa MF, Juhasz Z, Nagy Z. Event-Related Spectral Perturbation, Inter Trial Coherence, and Functional Connectivity in motor execution: A comparative EEG study of old and young subjects. Brain Behav 2023; 13:e3176. [PMID: 37624638 PMCID: PMC10454281 DOI: 10.1002/brb3.3176] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/17/2023] [Revised: 07/06/2023] [Accepted: 07/09/2023] [Indexed: 08/26/2023] Open
Abstract
INTRODUCTION The motor-related bioelectric brain activity of healthy young and old subjects was studied to understand the effect of aging on motor execution. A visually cued finger tapping movement paradigm and high-density EEG were used to examine the time and frequency characteristics. METHODS Twenty-two young and 22 healthy elderly adults participated in the study. Repeated trials of left and right index finger movements were recorded with a 128-channel EEG. Event-Related Spectral Perturbation (ERSP), Inter Trial Coherence (ITC), and Functional Connectivity were computed and compared between the age groups. RESULTS An age-dependent theta and alpha band ERSP decrease was observed over the frontal-midline area. Decrease of beta band ERSP was found over the ipsilateral central-parietal regions. Significant ITC differences were found in the delta and theta bands between old and young subjects over the contralateral parietal-occipital areas. The spatial extent of increased ITC values was larger in old subjects. The movement execution of older subjects showed higher global efficiency in the delta and theta bands, and higher local efficiency and node strengths in the delta, theta, alpha, and beta bands. CONCLUSION As functional compensation of aging, elderly motor networks involve more nonmotor, parietal-occipital, and frontal areas, with higher global and local efficiency, node strength. ERSP and ITC changes seem to be sensitive and complementary biomarkers of age-related motor execution.
Collapse
Affiliation(s)
- Adam Gyulai
- Szentagothai Doctoral SchoolSemmelweis UniversityBudapestHungary
- Department of NeurologyUzsoki HospitalBudapestHungary
- Laboratory of Bioelectric Brain ImagingNational Mental, Neurological and Neurosurgical InstituteBudapestHungary
| | - Janos Körmendi
- Laboratory of Bioelectric Brain ImagingNational Mental, Neurological and Neurosurgical InstituteBudapestHungary
- Department of Electrical Engineering and Information SystemsUniversity of PannoniaVeszpremHungary
- Faculty of Education and Psychology, Institute of Health Promotion and Sport SciencesEötvös Loránd UniversityBudapestHungary
| | - Mohamed F. Issa
- Department of Electrical Engineering and Information SystemsUniversity of PannoniaVeszpremHungary
- Faculty of Computers and Artificial Intelligence, Department of Scientific ComputingBenha UniversityBenhaEgypt
| | - Zoltan Juhasz
- Department of Electrical Engineering and Information SystemsUniversity of PannoniaVeszpremHungary
| | - Zoltan Nagy
- Laboratory of Bioelectric Brain ImagingNational Mental, Neurological and Neurosurgical InstituteBudapestHungary
- Department of Electrical Engineering and Information SystemsUniversity of PannoniaVeszpremHungary
- Department of Vascular NeurologySemmelweis UniversityBudapestHungary
| |
Collapse
|
5
|
Casas-Orozco D, Laky D, Mackey J, Reklaitis G, Nagy Z. Reaction kinetics determination and uncertainty analysis for the synthesis of the cancer drug lomustine. Chem Eng Sci 2023; 275:118591. [PMID: 38179266 PMCID: PMC10765472 DOI: 10.1016/j.ces.2023.118591] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/29/2023]
Abstract
Fast and reliable model development frameworks are required to support current trends in modernization of pharmaceutical processing, promoting the use of digital platforms to assist process design and operation. In this work, we use a parameter estimation framework built into the PharmaPy library to determine rate parameters and uncertainty regions of different mechanistic and semi-empirical kinetic expressions for the synthesis of the drug lomustine. The parameter estimation procedure was complemented by identifiability analysis, resulting in simplified reaction mechanisms. Comparison of parameters and their uncertainty in process design was demonstrated through design space analysis, showing important differences in model prediction and the extent of their corresponding design spaces. The results of this work can serve to analyze lomustine manufacturing processes that include separation and isolation steps, where parametric sensitivity is expected to propagate along the manufacturing line and impact process feasible operation, and attainment of critical quality attributes of the product.
Collapse
|
6
|
Dai TY, Radhakrishnan P, Nweye K, Estrada R, Niyogi D, Nagy Z. Analyzing the impact of COVID-19 on the electricity demand in Austin, TX using an ensemble-model based counterfactual and 400,000 smart meters. Comput Urban Sci 2023; 3:20. [PMID: 37192956 PMCID: PMC10162906 DOI: 10.1007/s43762-023-00095-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 01/29/2023] [Revised: 03/17/2023] [Accepted: 03/29/2023] [Indexed: 05/18/2023]
Abstract
The COVID-19 pandemic caused lifestyle changes and has led to the new electricity demand patterns in the presence of non-pharmaceutical interventions such as work-from-home policy and lockdown. Quantifying the effect on electricity demand is critical for future electricity market planning yet challenging in the context of limited smart metered buildings, which leads to limited understanding of the temporal and spatial variations in building energy use. This study uses a large scale private smart meter electricity demand data from the City of Austin, combined with publicly available environmental data, and develops an ensemble regression model for long term daily electricity demand prediction. Using 15-min resolution data from over 400,000 smart meters from 2018 to 2020 aggregated by building type and zip code, our proposed model precisely formalizes the counterfactual universe in the without COVID-19 scenario. The model is used to understand building electricity demand changes during the pandemic and to identify relationships between such changes and socioeconomic patterns. Results indicate the increase in residential usage , demonstrating the spatial redistribution of energy consumption during the work-from-home period. Our experiments demonstrate the effectiveness of our proposed framework by assessing multiple socioeconomic impacts with the comparison between the counterfactual universe and observations.
Collapse
Affiliation(s)
- Ting-Yu Dai
- Department of Civil, Environmental and Architectural Engineering, The University of Texas at Austin, Austin, 78712-1700 Texas USA
| | - Praveen Radhakrishnan
- Department of Civil, Environmental and Architectural Engineering, The University of Texas at Austin, Austin, 78712-1700 Texas USA
| | - Kingsley Nweye
- Department of Civil, Environmental and Architectural Engineering, The University of Texas at Austin, Austin, 78712-1700 Texas USA
| | - Robert Estrada
- Department of Civil, Environmental and Architectural Engineering, The University of Texas at Austin, Austin, 78712-1700 Texas USA
| | - Dev Niyogi
- Department of Civil, Environmental and Architectural Engineering, The University of Texas at Austin, Austin, 78712-1700 Texas USA
| | - Zoltan Nagy
- Department of Civil, Environmental and Architectural Engineering, The University of Texas at Austin, Austin, 78712-1700 Texas USA
| |
Collapse
|
7
|
Affiliation(s)
- Zoltan Nagy
- Institute of Experimental Biomedicine, University of Würzburg, University Hospital, Würzburg, Germany.,Rudolf Virchow Center for Integrative and Translational Bioimaging, University of Würzburg, Würzburg, Germany
| | - Bernhard Nieswandt
- Institute of Experimental Biomedicine, University of Würzburg, University Hospital, Würzburg, Germany.,Rudolf Virchow Center for Integrative and Translational Bioimaging, University of Würzburg, Würzburg, Germany
| |
Collapse
|
8
|
Fritz H, Tang M, Kinney K, Nagy Z. Evaluating machine learning models to classify occupants' perceptions of their indoor environment and sleep quality from indoor air quality. J Air Waste Manag Assoc 2022; 72:1381-1397. [PMID: 35939653 DOI: 10.1080/10962247.2022.2105439] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/04/2021] [Revised: 07/06/2022] [Accepted: 07/15/2022] [Indexed: 06/15/2023]
Abstract
A variety of factors can affect a person's perception of their environment and health, but one factor that is often overlooked in indoor settings is the air quality. To address this gap, we develop and evaluate four Machine Learning (ML) models on two disparate datasets using Indoor Air Quality (IAQ) parameters as primary features and components of self-reported IAQ satisfaction and sleep quality as target variables. In each case, we compare models to each other as well as to a simple model that always predicts the majority outcome. In the first analysis, we use open-source data collected from 93 California residences to predict occupant's satisfaction with their indoor environment. Results indicate building ventilation rate, Relative Humidity (RH), and formaldehyde are most influential when predicting IAQ perception and do so with an accuracy greater than the simplified model. The second analysis uses IAQ data gathered from a field study we conducted with 20 participants over 11 weeks to train similar models. We obtain accuracy and F1 scores similar to the simplified model where PM2.5 and TVOCs represent the most important predictors. Our results underscore the ability of IAQ to affect a person's perception of their built environment and health and highlight the utility of ML models to explore the strength of these relationships.Implications: The results from this study show that two outcome variables - occupant's indoor air quality (IAQ) satisfaction and perceived sleep quality - are related to the measured IAQ parameters but not heavily influenced by typical values measured in apartments and homes. This study highlights the ability of machine learning models as exploratory analysis tools to determine underlying relationships within and across datasets in addition to understanding the importance of certain features on the outcome variable. We compare four different models and find that the random forest classifier has the best performance in both analysis on IAQ satisfaction and perceived sleep quality. It is a suitable model for predicting IAQ-related subjective metrics and also provides value insight into the feature importance of the IAQ parameters. The accuracy of any of these machine learning models in predicting occupants' comfort or sleep quality is limited by the dataset size, how data is collected, and range of data. This study identifies the factors that are important to IAQ perception: ventilation rate, relative humidity, and concentrations of formaldehyde, NO2, and particulate matter. It indicates that sensors that can measure these variables are necessary for future, related studies that model occupants' IAQ satisfaction. However, this study does not find strong relationships between any of the IAQ parameters measured in this study and perceived sleep quality despite the logical pathway between these many pollutants and respiratory issues. A prediction model of IAQ perception or sleep quality can be integrated into home management systems to automatically adjust building operations such as ventilation rates in smart buildings. Once buildings are equipped with a network of low-cost sensors that measure concentrations of pollutants and operating conditions of the ventilation system, the prediction model can be used to predict the occupants' comfort and facilitate the control of the ventilation system.
Collapse
Affiliation(s)
- Hagen Fritz
- Department of Civil, Architectural and Environmental Engineering, University of Texas at Austin, Austin, Texas, USA
| | - Mengjia Tang
- Department of Civil, Architectural and Environmental Engineering, University of Texas at Austin, Austin, Texas, USA
| | - Kerry Kinney
- Department of Civil, Architectural and Environmental Engineering, University of Texas at Austin, Austin, Texas, USA
| | - Zoltan Nagy
- Department of Civil, Architectural and Environmental Engineering, University of Texas at Austin, Austin, Texas, USA
| |
Collapse
|
9
|
Mesterhazy A, Szieberth D, Tóth ET, Nagy Z, Szabó B, Herczig B, Bors I, Tóth B. The Role of Preharvest Natural Infection and Toxin Contamination in Food and Feed Safety in Maize, South-East Hungary, 2014–2021. J Fungi (Basel) 2022; 8:jof8101104. [PMID: 36294669 PMCID: PMC9605659 DOI: 10.3390/jof8101104] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2022] [Revised: 10/15/2022] [Accepted: 10/16/2022] [Indexed: 11/20/2022] Open
Abstract
Mycotoxins originating in the preharvest period represent a less studied research problem, even though they are of the utmost practical significance in maize production, determining marketability (within EU limits), and storage ability, competitiveness, and profit rate. In this study, 18–23 commercial hybrids were tested between 2014 and 2021. Natural infection from Fusarium spp. was higher than 1.5%, and for Aspergillus spp. this was normally 0.01% or 0, much lower than would be considered as severe infection. In spite of this, many hybrids provided far higher toxin contamination than regulations allow. The maximum preharvest aflatoxin B1 was in 2020 (at 2286 μg/kg), and, in several cases, the value was higher than 1000 μg/kg. The hybrid differences were large. In Hungary, the presence of field-originated aflatoxin B1 was continuous, with three AFB1 epidemics in the 8 years. The highest DON contamination was in 2014 (at 27 mg/kg), and a detectable DON level was found in every hybrid. FUMB1+B2 were the highest in 2014 (at 45.78 mg/kg). At these low infection levels, correlations between visual symptoms and toxin contaminations were mostly non-significant, so it is not feasible to draw a conclusion about toxin contamination from ear rot coverage alone. The toxin contamination of hybrids for a percentage of visual infection is highly variable, and only toxin data can decide about food safety. Hybrids with no visual symptoms and high AFB1 contamination were also identified. Preharvest control, including breeding and variety registration, is therefore of the utmost importance to all three pathogens. Even natural ear rot and toxin data do not prove differences in resistance, so a high ear rot or toxin contamination level should be considered as a risk factor for hybrids. The toxin control of freshly harvested grain is vital for separating healthy and contaminated lots. In addition, proper growing and storage conditions must be ensured to protect the feed safety of the grain.
Collapse
Affiliation(s)
- Akos Mesterhazy
- Cereal Research Non-Profit Ltd., Fesu Street 1, 6701 Szeged, Hungary
- Correspondence:
| | - Denes Szieberth
- Hungarian Maize Club, Kazinczy Str. 12, 8152 Kőszárhegy, Hungary
| | - Eva Toldine Tóth
- Cereal Research Non-Profit Ltd., Fesu Street 1, 6701 Szeged, Hungary
| | - Zoltan Nagy
- Cereal Research Non-Profit Ltd., Fesu Street 1, 6701 Szeged, Hungary
| | - Balazs Szabó
- Cereal Research Non-Profit Ltd., Fesu Street 1, 6701 Szeged, Hungary
| | - Beata Herczig
- Bonafarm-Babolna Feed Ltd., Laboratory Branch, 2942 Nagyigmand, Hungary
| | - Istvan Bors
- Bonafarm-Babolna Feed Ltd., Laboratory Branch, 2942 Nagyigmand, Hungary
| | - Beata Tóth
- Cereal Research Non-Profit Ltd., Fesu Street 1, 6701 Szeged, Hungary
| |
Collapse
|
10
|
Nagy Z, Hutton C, David G, Hinterholzer N, Deichmann R, Weiskopf N, Vannesjo SJ. HiHi fMRI: a data-reordering method for measuring the hemodynamic response of the brain with high temporal resolution and high SNR. Cereb Cortex 2022; 33:4606-4611. [PMID: 36169574 PMCID: PMC10110425 DOI: 10.1093/cercor/bhac364] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2022] [Revised: 08/19/2022] [Accepted: 08/22/2022] [Indexed: 11/14/2022] Open
Abstract
There is emerging evidence that sampling the blood-oxygen-level-dependent (BOLD) response with high temporal resolution opens up new avenues to study the in vivo functioning of the human brain with functional magnetic resonance imaging. Because the speed of sampling and the signal level are intrinsically connected in magnetic resonance imaging via the T1 relaxation time, optimization efforts usually must make a trade-off to increase the temporal sampling rate at the cost of the signal level. We present a method, which combines a sparse event-related stimulus paradigm with subsequent data reshuffling to achieve high temporal resolution while maintaining high signal levels (HiHi). The proof-of-principle is presented by separately measuring the single-voxel time course of the BOLD response in both the primary visual and primary motor cortices with 100-ms temporal resolution.
Collapse
Affiliation(s)
- Zoltan Nagy
- Laboratory for Social and Neural Systems Research (SNS Lab), University Hospital Zurich, Rämistrasse 100, University of Zurich, Zurich CH-8091, Switzerland.,Wellcome Centre for Human Neuroimaging, UCL Queen Square Institute of Neurology, 12 Queen Square, University College London, London WC1N 3BG, UK
| | - Chloe Hutton
- Wellcome Centre for Human Neuroimaging, UCL Queen Square Institute of Neurology, 12 Queen Square, University College London, London WC1N 3BG, UK
| | - Gergely David
- Spinal Cord Injury Center, Balgrist University Hospital, Forchstrasse 340, University of Zurich, Zurich CH-8008, Switzerland
| | - Natalie Hinterholzer
- SCMI, Swiss Center for Musculoskeletal Imaging, Balgrist Campus AG, Lengghalde 5, Zurich CH-8008, Switzerland
| | - Ralf Deichmann
- Wellcome Centre for Human Neuroimaging, UCL Queen Square Institute of Neurology, 12 Queen Square, University College London, London WC1N 3BG, UK.,Brain Imaging Centre, Goethe University Frankfurt, University Hospital Campus, Haus 95H, Schleusenweg 2-16, Frankfurt am Main D-60528, Germany
| | - Nikolaus Weiskopf
- Wellcome Centre for Human Neuroimaging, UCL Queen Square Institute of Neurology, 12 Queen Square, University College London, London WC1N 3BG, UK.,Department of Neurophysics, Max Planck Institute for Human Cognitive and Brain Sciences, Stephanstrasse 1a, Leipzig 04103, Germany
| | - S Johanna Vannesjo
- Department of Physics, Norwegian University of Science and Technology, Høgskoleringen 5, Trondheim 7491, Norway
| |
Collapse
|
11
|
Szabo Z, Ben Ahmed S, Nagy Z, Paczal A, Kotschy A. Enantioselective Cyclopropanation Catalyzed by Gold(I)-Carbene Complexes. Molecules 2022; 27:molecules27185805. [PMID: 36144540 PMCID: PMC9501563 DOI: 10.3390/molecules27185805] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2022] [Revised: 08/25/2022] [Accepted: 08/29/2022] [Indexed: 11/29/2022] Open
Abstract
The formation of polysubstituted cyclopropane derivatives in the gold(I)-catalyzed reaction of olefins and propargylic esters is a potentially useful transformation to generate diversity, therefore any method in which its stereoselectivity could be controlled is of significant interest. We prepared and tested a series of chiral gold(I)-carbene complexes as a catalyst in this transformation. With a systematic optimization of the reaction conditions, we were able to achieve high enantioselectivity in the test reaction while the cis:trans selectivity of the transformation was independent of the catalyst. Using the optimized conditions, we reacted a series of various olefins and acetylene derivatives to find that, although the reactions proceeded smoothly and the products were usually isolated in good yield and with good to exclusive cis selectivity, the observed enantioselectivity varied greatly and was sometimes moderate at best. We were unable to establish any structure-property relationship, which suggests that for any given reagent combination, one has to identify individually the best catalyst.
Collapse
|
12
|
Baumann J, Sachs L, Otto O, Schoen I, Nestler P, Zaninetti C, Kenny M, Kranz R, von Eysmondt H, Rodriguez J, Schäffer TE, Nagy Z, Greinacher A, Palankar R, Bender M. Reduced platelet forces underlie impaired hemostasis in mouse models of MYH9-related disease. Sci Adv 2022; 8:eabn2627. [PMID: 35584211 PMCID: PMC9116608 DOI: 10.1126/sciadv.abn2627] [Citation(s) in RCA: 15] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/05/2023]
Abstract
MYH9-related disease patients with mutations in the contractile protein nonmuscle myosin heavy chain IIA display, among others, macrothrombocytopenia and a mild-to-moderate bleeding tendency. In this study, we used three mouse lines, each with one point mutation in the Myh9 gene at positions 702, 1424, or 1841, to investigate mechanisms underlying the increased bleeding risk. Agonist-induced activation of Myh9 mutant platelets was comparable to controls. However, myosin light chain phosphorylation after activation was reduced in mutant platelets, which displayed altered biophysical characteristics and generated lower adhesion, interaction, and traction forces. Treatment with tranexamic acid restored clot retraction in the presence of tPA and reduced bleeding. We verified our findings from the mutant mice with platelets from patients with the respective mutation. These data suggest that reduced platelet forces lead to an increased bleeding tendency in patients with MYH9-related disease, and treatment with tranexamic acid can improve the hemostatic function.
Collapse
Affiliation(s)
- Juliane Baumann
- Institute of Experimental Biomedicine—Chair I, University Hospital and Rudolf Virchow Center, Würzburg, Germany
| | - Laura Sachs
- Institute for Immunology and Transfusion Medicine, University Medicine Greifswald, Greifswald, Germany
| | - Oliver Otto
- Zentrum für Innovationskompetenz—Humorale Immunreaktionen bei Kardiovaskulären Erkrankungen, University Greifswald, Greifswald, Germany
- Deutsches Zentrum für Herz-Kreislauf-Forschung e. V., Standort Greifswald, Universitätsmedizin Greifswald, Greifswald, Germany
| | - Ingmar Schoen
- School of Pharmacy and Biomolecular Sciences, Irish Centre for Vascular Biology, Royal College of Surgeons in Ireland, Dublin, Ireland
| | - Peter Nestler
- Zentrum für Innovationskompetenz—Humorale Immunreaktionen bei Kardiovaskulären Erkrankungen, University Greifswald, Greifswald, Germany
| | - Carlo Zaninetti
- Institute for Immunology and Transfusion Medicine, University Medicine Greifswald, Greifswald, Germany
- University of Pavia, Pavia, Italy
| | - Martin Kenny
- School of Pharmacy and Biomolecular Sciences, Irish Centre for Vascular Biology, Royal College of Surgeons in Ireland, Dublin, Ireland
| | - Ruth Kranz
- Institute of Experimental Biomedicine—Chair I, University Hospital and Rudolf Virchow Center, Würzburg, Germany
| | | | - Johanna Rodriguez
- Institute of Applied Physics, University of Tübingen, Tübingen, Germany
| | | | - Zoltan Nagy
- Institute of Experimental Biomedicine—Chair I, University Hospital and Rudolf Virchow Center, Würzburg, Germany
| | - Andreas Greinacher
- Institute for Immunology and Transfusion Medicine, University Medicine Greifswald, Greifswald, Germany
| | - Raghavendra Palankar
- Institute for Immunology and Transfusion Medicine, University Medicine Greifswald, Greifswald, Germany
- Corresponding author. (M.B.); (R.P.)
| | - Markus Bender
- Institute of Experimental Biomedicine—Chair I, University Hospital and Rudolf Virchow Center, Würzburg, Germany
- Corresponding author. (M.B.); (R.P.)
| |
Collapse
|
13
|
Huang YS, Medina-González S, Straiton B, Keller J, Marashdeh Q, Gonzalez M, Nagy Z, Reklaitis GV. Real-Time Monitoring of Powder Mass Flowrates for Plant-Wide Control of a Continuous Direct Compaction Tablet Manufacturing Process. J Pharm Sci 2022; 111:69-81. [PMID: 34126119 PMCID: PMC10009918 DOI: 10.1016/j.xphs.2021.06.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2021] [Revised: 06/02/2021] [Accepted: 06/02/2021] [Indexed: 11/28/2022]
Abstract
While measurement and monitoring of powder/particulate mass flow rate are not essential to the execution of traditional batch pharmaceutical tablet manufacturing, in continuous operation, it is an important additional critical process parameter. It has a key role both in establishing that the process is in a state of control, and as a controlled variable in process control system design. In current continuous tableting line operations, the pharmaceutical community relies on loss-in-weight feeders to monitor and understand upstream powder flow dynamics. However, due to the absence of established sensing technologies for measuring particulate flow rates, the downstream flow of the feeders is monitored and controlled using various indirect strategies. For example, the hopper level of the tablet press is maintained as a controlled process output by adjusting the turret speed of the tablet press, which indirectly controlling the flow rate. This gap in monitoring and control of the critical process flow motivates our investigation of a novel PAT tool, a capacitance-based sensor (ECVT), and its effective integration into the plant-wide control of a direct compaction process. First, the results of stand-alone experimental studies are reported, which confirm that the ECVT sensor can provide real-time measurements of mass flow rate with measurement error within -1.8 ~ 3.3% and with RMSE of 0.1 kg/h over the range of flow rates from 2 to 10 kg/h. The key caveat is that the powder flowability has to be good enough to avoid powder fouling on the transfer line walls. Next, simulation case studies are carried out using a dynamic flowsheet model of a continuous direct compression line implemented in Matlab/Simulink to demonstrate the potential structural and performance advantages in plant-wide process control enabled by mass flow sensing. Finally, experimental studies are performed on a direct compaction pilot plant in which the ECVT sensor is located at the exit of the blender, to confirm that the powder flow can be monitored instantaneously and controlled effectively at the specified setpoint within a plant-wide feedback controller system.
Collapse
Affiliation(s)
- Yan-Shu Huang
- Davidson School of Chemical Engineering, Purdue University, West Lafayette, IN 47907, United States.
| | - Sergio Medina-González
- Davidson School of Chemical Engineering, Purdue University, West Lafayette, IN 47907, United States
| | | | | | | | - Marcial Gonzalez
- School of Mechanical Engineering, Purdue University, West Lafayette, IN 47907, United States
| | - Zoltan Nagy
- Davidson School of Chemical Engineering, Purdue University, West Lafayette, IN 47907, United States
| | - Gintaras V Reklaitis
- Davidson School of Chemical Engineering, Purdue University, West Lafayette, IN 47907, United States
| |
Collapse
|
14
|
Lagare RB, da Conceicao MA, Camille Acevedo Rosario A, Leigh Young K, Huang YS, Sheriff MZ, Clementson C, Mort P, Nagy Z, Reklaitis GV. Development of a Virtual Sensor for Real-Time Prediction of Granule Flow Properties. ESCAPE 2022; 51:1081-1086. [PMID: 36790943 PMCID: PMC9923503 DOI: 10.1016/b978-0-323-95879-0.50181-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
We report progress of an ongoing work to develop a virtual sensor for flowability, which is a critical tool for enabling real time process monitoring in a granulation line. The sensor is based on camera imaging to measure the size and shape distribution of granules produced by wet granulation. Then, statistical methods were used to correlate them with flowability measurements such as ring shear tests, drained angle of repose, dynamic angle of repose, and tapped density. The virtual sensor addresses the issue with these flowability measurements, which are based on off-line characterization methods that can take hours to perform. With a virtual sensor based on real-time measurement methods, the prediction of granule flowability become faster, allowing for timely decisions regarding process control and the supply chain.
Collapse
Affiliation(s)
- Rexonni B. Lagare
- Davidson School of Chemical Engineering, Purdue University, West Lafayette, IN 47907, USA
| | | | | | - Katherine Leigh Young
- Davidson School of Chemical Engineering, Purdue University, West Lafayette, IN 47907, USA
| | - Yan-Shu Huang
- Davidson School of Chemical Engineering, Purdue University, West Lafayette, IN 47907, USA
| | - M. Ziyan Sheriff
- Davidson School of Chemical Engineering, Purdue University, West Lafayette, IN 47907, USA
| | - Clairmont Clementson
- Purdue Center for Particulate Products and Processes, West Lafayette, IN 47907, USA
| | - Paul Mort
- School of Materials Engineering, Purdue University, West Lafayette, IN 47907, USA
| | - Zoltan Nagy
- Davidson School of Chemical Engineering, Purdue University, West Lafayette, IN 47907, USA
| | - Gintaras V. Reklaitis
- Davidson School of Chemical Engineering, Purdue University, West Lafayette, IN 47907, USA,Purdue Center for Particulate Products and Processes, West Lafayette, IN 47907, USA
| |
Collapse
|
15
|
Lagare RB, Sheriff MZ, Gonzalez M, Nagy Z, Reklaitis GV. A Comprehensive Framework for the Modular Development of Condition Monitoring Systems for a Continuous Dry Granulation Line. Int Symp Process Syst Eng 2022; 49:1543-1548. [PMID: 36790940 PMCID: PMC9923506 DOI: 10.1016/b978-0-323-85159-6.50257-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
The development of condition monitoring systems often follows a modular scheme where some systems are already embedded in certain equipment by their manufacturers, and some are distributed across various equipment and instruments. This work introduces a framework for guiding the modular development of monitoring systems and integrating them into a comprehensive model that can handle uncertainty of predictions from the constituent modules. Furthermore, this framework improves the robustness of the modular condition monitoring systems as it provides a methodology for maintaining quality assurance and preventing unnecessary shutdowns in the event of some modules going off-line due to condition-based maintenance interventions.
Collapse
Affiliation(s)
- Rexonni B. Lagare
- Davidson School of Chemical Engineering, Purdue University, West Lafayette, IN 47907, USA
| | - M. Ziyan Sheriff
- Davidson School of Chemical Engineering, Purdue University, West Lafayette, IN 47907, USA
| | - Marcial Gonzalez
- School of Mechanical Engineering, Purdue University, West Lafayette, IN 47907, USA
| | - Zoltan Nagy
- Davidson School of Chemical Engineering, Purdue University, West Lafayette, IN 47907, USA
| | - Gintaras V. Reklaitis
- Davidson School of Chemical Engineering, Purdue University, West Lafayette, IN 47907, USA
| |
Collapse
|
16
|
Spearing L, Tiedmann HR, Sela L, Nagy Z, Kaminsky JA, Katz LE, Kinney KA, Kirisits MJ, Faust KM. Human-Infrastructure Interactions during the COVID-19 Pandemic: Understanding Water and Electricity Demand Profiles at the Building Level. ACS ES T Water 2021; 1:2327-2338. [PMID: 34778873 PMCID: PMC8577189 DOI: 10.1021/acsestwater.1c00176] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 05/26/2021] [Revised: 10/14/2021] [Accepted: 10/15/2021] [Indexed: 06/13/2023]
Abstract
When engineers design and manage a building's water and electricity utilities, they must make assumptions about resource use. These assumptions are often challenged when unexpected changes in demand occur, such as the spatial and temporal changes observed during the coronavirus (COVID-19) pandemic. Social distancing policies (SDPs) enacted led many universities to close their campuses and implement remote learning, impacting utility consumption patterns. Yet, little is known about how consumption changed at the building level. Here, we aim to understand how water and electricity consumption changed during the pandemic by identifying characteristic weekly demand profiles and understanding how these changes were related to regulatory and social systems. We performed k-means clustering on utility demand data measured before and as the pandemic evolved from five buildings of different types at the University of Texas at Austin. As expected, after SDPs were enacted both water and electricity use shifted, with most buildings seeing a sharp initial decline that remained low until the university partially reopened. In contrast to electricity use, we found that water use was tightly coupled with SDPs. Our study provides actionable information for managers to mitigate negative impacts (e.g., water stagnation) and capitalize on opportunities to minimize resource use.
Collapse
Affiliation(s)
- Lauryn
A. Spearing
- Civil,
Architectural and Environmental Engineering, The University of Texas at Austin, 301 Dean Keeton C1752, Austin, Texas 78751, United States
| | - Helena R. Tiedmann
- Civil,
Architectural and Environmental Engineering, The University of Texas at Austin, 301 Dean Keeton C1752, Austin, Texas 78751, United States
| | - Lina Sela
- Civil,
Architectural and Environmental Engineering, The University of Texas at Austin, 301 Dean Keeton C1752, Austin, Texas 78751, United States
| | - Zoltan Nagy
- Civil,
Architectural and Environmental Engineering, The University of Texas at Austin, 301 Dean Keeton C1752, Austin, Texas 78751, United States
| | - Jessica A. Kaminsky
- Civil
and Environmental Engineering, The University
of Washington, 3760 E. Stevens Way NE, Seattle, Washington 98195, United States
| | - Lynn E. Katz
- Civil,
Architectural and Environmental Engineering, The University of Texas at Austin, 301 Dean Keeton C1752, Austin, Texas 78751, United States
| | - Kerry A. Kinney
- Civil,
Architectural and Environmental Engineering, The University of Texas at Austin, 301 Dean Keeton C1752, Austin, Texas 78751, United States
| | - Mary Jo Kirisits
- Civil,
Architectural and Environmental Engineering, The University of Texas at Austin, 301 Dean Keeton C1752, Austin, Texas 78751, United States
| | - Kasey M. Faust
- Civil,
Architectural and Environmental Engineering, The University of Texas at Austin, 301 Dean Keeton C1752, Austin, Texas 78751, United States
| |
Collapse
|
17
|
Cottaar M, Wu W, Tendler BC, Nagy Z, Miller K, Jbabdi S. Quantifying myelin in crossing fibers using diffusion-prepared phase imaging: Theory and simulations. Magn Reson Med 2021; 86:2618-2634. [PMID: 34254349 PMCID: PMC8581995 DOI: 10.1002/mrm.28907] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2020] [Revised: 06/03/2021] [Accepted: 06/08/2021] [Indexed: 11/24/2022]
Abstract
PURPOSE Myelin has long been the target of neuroimaging research. However, most available techniques can only provide a voxel-averaged estimate of myelin content. In the human brain, white matter fiber pathways connecting different brain areas and carrying different functions often cross each other in the same voxel. A measure that can differentiate the degree of myelination of crossing fibers would provide a more specific marker of myelination. THEORY AND METHODS One MRI signal property that is sensitive to myelin is the phase accumulation. This sensitivity is used by measuring the phase accumulation of the signal remaining after diffusion-weighting, which is called diffusion-prepared phase imaging (DIPPI). Including diffusion-weighting before estimating the phase accumulation has two distinct advantages for estimating the degree of myelination: (1) It increases the relative contribution of intra-axonal water, whose phase is related linearly to the thickness of the surrounding myelin (in particular the log g-ratio); and (2) it gives directional information, which can be used to distinguish between crossing fibers. Here the DIPPI sequence is described, an approach is proposed to estimate the log g-ratio, and simulations are used and DIPPI data acquired in an isotropic phantom to quantify other sources of phase accumulation. RESULTS The expected bias is estimated in the log g-ratio for reasonable in vivo acquisition parameters caused by eddy currents (~4%-10%), remaining extra-axonal signal (~15%), and gradients in the bulk off-resonance field (<10% for most of the brain). CONCLUSION This new sequence may provide a g-ratio estimate per fiber population crossing within a voxel.
Collapse
Affiliation(s)
- Michiel Cottaar
- Wellcome Centre for Integrative Neuroimaging—Centre for Functional Magnetic Resonance Imaging of the BrainJohn Radcliffe HospitalUniversity of OxfordOxfordUnited Kingdom
| | - Wenchuan Wu
- Wellcome Centre for Integrative Neuroimaging—Centre for Functional Magnetic Resonance Imaging of the BrainJohn Radcliffe HospitalUniversity of OxfordOxfordUnited Kingdom
| | - Benjamin C. Tendler
- Wellcome Centre for Integrative Neuroimaging—Centre for Functional Magnetic Resonance Imaging of the BrainJohn Radcliffe HospitalUniversity of OxfordOxfordUnited Kingdom
| | - Zoltan Nagy
- Laboratory for Social and Neural Systems ResearchUniversity of ZurichZurichSwitzerland
| | - Karla Miller
- Wellcome Centre for Integrative Neuroimaging—Centre for Functional Magnetic Resonance Imaging of the BrainJohn Radcliffe HospitalUniversity of OxfordOxfordUnited Kingdom
| | - Saad Jbabdi
- Wellcome Centre for Integrative Neuroimaging—Centre for Functional Magnetic Resonance Imaging of the BrainJohn Radcliffe HospitalUniversity of OxfordOxfordUnited Kingdom
| |
Collapse
|
18
|
Bodart J, Dufeys C, Senis YA, Nagy Z, Bertrand L, Beauloye C, Lucas S, Horman S. Role of platelet GARP in TGFB activation. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.3245] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Introduction
Transforming growth factor (TGF)β is known to be a central player in the control of cardiac fibroblast properties and fibrosis. However, cellular and molecular mechanisms that trigger its activation remain poorly understood. Platelets are considered as a major source of TGFβ and recent evidence suggest that they are involved in TGFβ activation via Glycoprotein A Repetitions Predominant (GARP) present on their surface.
Purpose
The present study sought to evaluate the role of platelet GARP in TGFβ activation using platelet specific GARP knockout mice.
Methods
We generated a new Cre transgenic mouse strain that allowed Megakaryocyte/platelet specific invalidation of GARP (GpIba-Cre x GARPfl/fl). The impact of GARP deficiency on platelet function was measured in vitro by flow cytometry using thrombin and CRP. Serum production of total and active TGFβ was assessed by ELISA.
Results
Platelet count and other hematological parameters were normal in platelet specific GARP knockout mice, except platelet volume, which was increased by 10.3%, as compared to wild-type platelets. Stimulation by thrombin and CRP increased GARP exposure at platelet surface. However, platelets without GARP displayed normal agonist induced activation, as reflected by CD62P and αIIbβ3 exposure. Interestingly, the generation of active TGFβ was drastically impaired in the serum of platelet specific GARP knockout mice, while the amount of total TGFβ was not affected.
Conclusion
We provided evidence that platelet GARP is a crucial contributor to the systemic activation of TGFβ. Future work will aim to determine its role in cardiac fibroblast myodifferentiation and fibrosis.
Funding Acknowledgement
Type of funding sources: Other. Main funding source(s): FRIA
Collapse
Affiliation(s)
- J Bodart
- Universite Catholique de Louvain, Brussels, Belgium
| | - C Dufeys
- Universite Catholique de Louvain, Brussels, Belgium
| | - Y A Senis
- Institut National de la Santé et de la Recherche Médicale, Strasbourg, France
| | - Z Nagy
- Université de Würzburg, Würzburg, Germany
| | - L Bertrand
- Universite Catholique de Louvain, Brussels, Belgium
| | - C Beauloye
- Universite Catholique de Louvain, Brussels, Belgium
| | - S Lucas
- Universite Catholique de Louvain, Brussels, Belgium
| | - S Horman
- Universite Catholique de Louvain, Brussels, Belgium
| |
Collapse
|
19
|
Octave M, Pirotton L, Ginion A, Robaux V, Lepropre S, Kautbally S, Senis Y, Nagy Z, Ambroise J, Guigas B, Giera M, Bertrand L, Beauloye C, Horman S. Platelet-specific deletion of acetyl-CoA carboxylase 1 decreases phospholipid content and impairs platelet functions. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.3373] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Acetyl-CoA carboxylase (ACC), the first enzyme regulating lipid synthesis, promotes thrombus formation by increasing platelet phospholipid content and thromboxane A2 generation.
Purpose
Our study sought to evaluate whether ACC1 platelet-specific deletion may affect platelet functions by decreasing phospholipid content.
Methods
We generated a new Cre transgenic mouse strain that allows megakaryocyte/platelet specific ACC1 deletion (GpIbCre+/− x ACC1 flx/flx mouse). In vitro, platelet functions were assessed by aggregometry and flow cytometry. In vivo, hemostasis was assessed via the measurement of bleeding time. Lipidomics analysis was carried out on the commercial Lipidyzer platform. Thromboxane A2 secretion was evaluated by ELISA.
Results
As expected, ACC1 deletion was restricted to the megakaryocytic lineage. Hematological parameters in platelet-specific ACC1 knockout mice showed a decrease in platelet count by 30% and an increase in platelet volume by 31%, compared to ACC1 flx/flx platelets. In vitro, platelets from platelet-specific ACC1 knockout mice displayed a decrease in thrombin and CRP-induced platelet aggregation, associated with impaired dense granules secretion. In contrast, ADP-induced platelet aggregation was higher in the absence of ACC1. In vivo, platelet-specific ACC1 knockout mice showed a normal bleeding time. In agreement with our hypothesis, lipidomics analyses showed that ACC1 deletion in platelets was associated with a significant decrease in arachidonic acid-contaning phosphatidylethanolamine plasmalogen, and subsequently with a reduced production of thromboxane A2 upon thrombin or CRP stimulation.
Conclusion
Platelet-specific ACC1 deletion led to a decrease in phospholipid content which, in turn, decreased platelet thromboxane A2 generation, dense granules secretion and aggregation upon thrombin and CRP, but not ADP stimulation. Further studies are needed to elucidate the impact of ADP on platelet functions
Funding Acknowledgement
Type of funding sources: Other. Main funding source(s): Fonds pour la formation à la Recherche dans l'Industrie et l'Agriculture (FRIA)
Collapse
Affiliation(s)
- M Octave
- Institute of Experimental and Clinical Research (IREC), Pole of cardiovascular research (CARD), Brussels, Belgium
| | - L Pirotton
- Institute of Experimental and Clinical Research (IREC), Pole of cardiovascular research (CARD), Brussels, Belgium
| | - A Ginion
- Institute of Experimental and Clinical Research (IREC), Pole of cardiovascular research (CARD), Brussels, Belgium
| | - V Robaux
- Institute of Experimental and Clinical Research (IREC), Pole of cardiovascular research (CARD), Brussels, Belgium
| | - S Lepropre
- Institute of Experimental and Clinical Research (IREC), Pole of cardiovascular research (CARD), Brussels, Belgium
| | - S Kautbally
- Institute of Experimental and Clinical Research (IREC), Pole of cardiovascular research (CARD), Brussels, Belgium
| | - Y Senis
- University of Strasbourg, Etablissement Français du Sang Grand Est, Unité Mixte de Recherche (UMR)-S 1255, Strasbourg, France
| | - Z Nagy
- University Hospital of Wurzburg, Wurzburg, Germany
| | - J Ambroise
- Institute of Experimental and Clinical Research (IREC), Centre de technologies moléculaires appliquées, Brussels, Belgium
| | - B Guigas
- Leiden University Medical Center, Leiden, Netherlands (The)
| | - M Giera
- Leiden University Medical Center, Leiden, Netherlands (The)
| | - L Bertrand
- Institute of Experimental and Clinical Research (IREC), Pole of cardiovascular research (CARD), Brussels, Belgium
| | - C Beauloye
- Institute of Experimental and Clinical Research (IREC), Pole of cardiovascular research (CARD), Brussels, Belgium
| | - S Horman
- Institute of Experimental and Clinical Research (IREC), Pole of cardiovascular research (CARD), Brussels, Belgium
| |
Collapse
|
20
|
Gyulai A, Körmendi J, Juhasz Z, Nagy Z. Inter trial coherence of low-frequency oscillations in the course of stroke recovery. Clin Neurophysiol 2021; 132:2447-2455. [PMID: 34454272 DOI: 10.1016/j.clinph.2021.06.034] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/04/2020] [Revised: 06/08/2021] [Accepted: 06/26/2021] [Indexed: 11/25/2022]
Abstract
OBJECTIVE The aim was to find a sensitive method to highlight the remodeling of the brain's bioelectric activity in post-stroke repair. METHODS Fifteen mild upper limb paretic stroke patients and age-matched healthy controls were included. Repeated trials of finger tapping around the 10th and 100th days after stroke onset were recorded with a 128-channel EEG. Power spectra and Inter Trial Coherence (ITC) calculations were synchronized to tappings. ITC was correlated with motor performance. RESULTS ITC, in low frequency bands, designates the motor related bioelectric activity in channel space in both healthy subjects and patients. Ten days after stroke onset, delta-theta ITC was severely reduced compared to baseline, while three months later ITC reorganized partially over the ipsilesional central-parietal areas reflecting the improvement of motor networks. Decreased ITC in the central-parietal area remained significant compared to controls. Delta band ITC over the dorsolateral-prefrontal cortex correlates with the performance on Nine Hole Peg Test. At post-recovery, non-paretic hand tappings show significantly decreased delta-theta ITC over the supplementary motor area, which reflects network remodeling. CONCLUSIONS Inter Trial Coherence is a useful measure of brain reorganization during stroke recovery. SIGNIFICANCE Delta- theta ITC is a sensitive indicator of impaired motor execution.
Collapse
Affiliation(s)
- Adam Gyulai
- Uzsoki Hospital, Uzsoki u. 29-41., 1145 Budapest, Hungary; National Institute of Clinical Neurosciences, Laky Adolf u. 44-46., 1145 Budapest, Hungary; Semmelweis University, Üllői út 26., 1085 Budapest, Hungary.
| | - Janos Körmendi
- National Institute of Clinical Neurosciences, Laky Adolf u. 44-46., 1145 Budapest, Hungary; Department of Electrical Engineering and Information Systems, University of Pannonia, Egyetem u. 10., 8200 Veszprem, Hungary; Institute of Health Promotion and Sport Sciences, Faculty of Education and Psychology, Eötvös Loránd University, Bogdánfy Ödön u. 10., 1117 Budapest, Hungary
| | - Zoltan Juhasz
- Department of Electrical Engineering and Information Systems, University of Pannonia, Egyetem u. 10., 8200 Veszprem, Hungary
| | - Zoltan Nagy
- National Institute of Clinical Neurosciences, Laky Adolf u. 44-46., 1145 Budapest, Hungary; Semmelweis University, Üllői út 26., 1085 Budapest, Hungary; Department of Electrical Engineering and Information Systems, University of Pannonia, Egyetem u. 10., 8200 Veszprem, Hungary.
| |
Collapse
|
21
|
Scheller I, Beck S, Göb V, Gross C, Neagoe RAI, Aurbach K, Bender M, Stegner D, Nagy Z, Nieswandt B. Thymosin β4 is essential for thrombus formation by controlling the G-actin/F-actin equilibrium in platelets. Haematologica 2021; 107:2846-2858. [PMID: 34348450 PMCID: PMC9713564 DOI: 10.3324/haematol.2021.278537] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/11/2021] [Indexed: 12/14/2022] Open
Abstract
Coordinated rearrangements of the actin cytoskeleton are pivotal for platelet biogenesis from megakaryocytes but also orchestrate key functions of peripheral platelets in hemostasis and thrombosis, such as granule release, the formation of filopodia and lamellipodia, or clot retraction. Along with profilin (Pfn) 1, thymosin β4 (encoded by Tmsb4x) is one of the two main G-actin-sequestering proteins within cells of higher eukaryotes, and its intracellular concentration is particularly high in cells that rapidly respond to external signals by increased motility, such as platelets. Here, we analyzed constitutive Tmsb4x knockout (KO) mice to investigate the functional role of the protein in platelet production and function. Thymosin β4 deficiency resulted in a macrothrombocytopenia with only mildly increased platelet volume and an unaltered platelet life span. Megakaryocyte numbers in the bone marrow and spleen were unaltered, however, Tmsb4x KO megakaryocytes showed defective proplatelet formation in vitro and in vivo. Thymosin β4-deficient platelets displayed markedly decreased G-actin levels and concomitantly increased F-actin levels resulting in accelerated spreading on fibrinogen and clot retraction. Moreover, Tmsb4x KO platelets showed activation defects and an impaired immunoreceptor tyrosine-based activation motif (ITAM) signaling downstream of the activating collagen receptor glycoprotein VI. These defects translated into impaired aggregate formation under flow, protection from occlusive arterial thrombus formation in vivo and increased tail bleeding times. In summary, these findings point to a critical role of thymosin β4 for actin dynamics during platelet biogenesis, platelet activation downstream of glycoprotein VI and thrombus stability.
Collapse
Affiliation(s)
- Inga Scheller
- Institute of Experimental Biomedicine I, University Hospital, University of Würzburg, and Rudolf Virchow Center for Integrative and Translational BioImaging, University of Würzburg, Würzburg, Germany,*IS and SB contributed equally as co-first authors
| | - Sarah Beck
- Institute of Experimental Biomedicine I, University Hospital, University of Würzburg, and Rudolf Virchow Center for Integrative and Translational BioImaging, University of Würzburg, Würzburg, Germany,*IS and SB contributed equally as co-first authors
| | - Vanessa Göb
- Institute of Experimental Biomedicine I, University Hospital, University of Würzburg, and Rudolf Virchow Center for Integrative and Translational BioImaging, University of Würzburg, Würzburg, Germany
| | - Carina Gross
- Institute of Experimental Biomedicine I, University Hospital, University of Würzburg, and Rudolf Virchow Center for Integrative and Translational BioImaging, University of Würzburg, Würzburg, Germany
| | - Raluca A. I. Neagoe
- Institute of Experimental Biomedicine I, University Hospital, University of Würzburg, and Rudolf Virchow Center for Integrative and Translational BioImaging, University of Würzburg, Würzburg, Germany,Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, UK
| | - Katja Aurbach
- Institute of Experimental Biomedicine I, University Hospital, University of Würzburg, and Rudolf Virchow Center for Integrative and Translational BioImaging, University of Würzburg, Würzburg, Germany
| | - Markus Bender
- Institute of Experimental Biomedicine I, University Hospital, University of Würzburg, and Rudolf Virchow Center for Integrative and Translational BioImaging, University of Würzburg, Würzburg, Germany
| | - David Stegner
- Institute of Experimental Biomedicine I, University Hospital, University of Würzburg, and Rudolf Virchow Center for Integrative and Translational BioImaging, University of Würzburg, Würzburg, Germany
| | - Zoltan Nagy
- Institute of Experimental Biomedicine I, University Hospital, University of Würzburg, and Rudolf Virchow Center for Integrative and Translational BioImaging, University of Würzburg, Würzburg, Germany
| | - Bernhard Nieswandt
- Institute of Experimental Biomedicine I, University Hospital, University of Würzburg, and Rudolf Virchow Center for Integrative and Translational BioImaging, University of Würzburg, Würzburg, Germany,B. Nieswandt
| |
Collapse
|
22
|
Wu C, Fritz H, Bastami S, Maestre JP, Thomaz E, Julien C, Castelli DM, de Barbaro K, Bearman SK, Harari GM, Cameron Craddock R, Kinney KA, Gosling SD, Schnyer DM, Nagy Z. Multi-modal data collection for measuring health, behavior, and living environment of large-scale participant cohorts. Gigascience 2021; 10:giab044. [PMID: 34155505 PMCID: PMC8216865 DOI: 10.1093/gigascience/giab044] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2020] [Revised: 03/09/2021] [Indexed: 11/15/2022] Open
Abstract
BACKGROUND As mobile technologies become ever more sensor-rich, portable, and ubiquitous, data captured by smart devices are lending rich insights into users' daily lives with unprecedented comprehensiveness and ecological validity. A number of human-subject studies have been conducted to examine the use of mobile sensing to uncover individual behavioral patterns and health outcomes, yet minimal attention has been placed on measuring living environments together with other human-centered sensing data. Moreover, the participant sample size in most existing studies falls well below a few hundred, leaving questions open about the reliability of findings on the relations between mobile sensing signals and human outcomes. RESULTS To address these limitations, we developed a home environment sensor kit for continuous indoor air quality tracking and deployed it in conjunction with smartphones, Fitbits, and ecological momentary assessments in a cohort study of up to 1,584 college student participants per data type for 3 weeks. We propose a conceptual framework that systematically organizes human-centric data modalities by their temporal coverage and spatial freedom. Then we report our study procedure, technologies and methods deployed, and descriptive statistics of the collected data that reflect the participants' mood, sleep, behavior, and living environment. CONCLUSIONS We were able to collect from a large participant cohort satisfactorily complete multi-modal sensing and survey data in terms of both data continuity and participant adherence. Our novel data and conceptual development provide important guidance for data collection and hypothesis generation in future human-centered sensing studies.
Collapse
Affiliation(s)
- Congyu Wu
- Department of Psychology, University of Texas at Austin, 108 E Dean Keeton St, Austin, Texas, 78712, USA
| | - Hagen Fritz
- Department of Civil, Environmental, and Architectural Engineering, University of Texas at Austin, 301 E Dean Keeton St, Austin, Texas, 78712, USA
| | - Sepehr Bastami
- Department of Civil, Environmental, and Architectural Engineering, University of Texas at Austin, 301 E Dean Keeton St, Austin, Texas, 78712, USA
| | - Juan P Maestre
- Department of Civil, Environmental, and Architectural Engineering, University of Texas at Austin, 301 E Dean Keeton St, Austin, Texas, 78712, USA
| | - Edison Thomaz
- Department of Electrical and Computer Engineering, University of Texas at Austin, 2501 Speedway, Austin, Texas, 78712, USA
| | - Christine Julien
- Department of Electrical and Computer Engineering, University of Texas at Austin, 2501 Speedway, Austin, Texas, 78712, USA
| | - Darla M Castelli
- Department of Kinesiology and Health Education, University of Texas at Austin, 2109 San Jacinto Blvd, Austin, Texas, 78712, USA
| | - Kaya de Barbaro
- Department of Psychology, University of Texas at Austin, 108 E Dean Keeton St, Austin, Texas, 78712, USA
| | - Sarah Kate Bearman
- Department of Educational Psychology, University of Texas at Austin, 1912 Speedway, Austin, Texas, 78712, USA
| | - Gabriella M Harari
- Department of Communication, Stanford University, 450 Serra Mall, Stanford, California, 94305, USA
| | - R Cameron Craddock
- Department of Diagnostic Medicine, University of Texas at Austin, 1601 Trinity St, Austin, Texas, 78712, USA
| | - Kerry A Kinney
- Department of Civil, Environmental, and Architectural Engineering, University of Texas at Austin, 301 E Dean Keeton St, Austin, Texas, 78712, USA
| | - Samuel D Gosling
- Department of Psychology, University of Texas at Austin, 108 E Dean Keeton St, Austin, Texas, 78712, USA
- Melbourne School of Psychological Sciences, University of Melbourne, Grattan Street, Parkville, Victoria, 3010, Australia
| | - David M Schnyer
- Department of Psychology, University of Texas at Austin, 108 E Dean Keeton St, Austin, Texas, 78712, USA
| | - Zoltan Nagy
- Department of Civil, Environmental, and Architectural Engineering, University of Texas at Austin, 301 E Dean Keeton St, Austin, Texas, 78712, USA
| |
Collapse
|
23
|
Kardos A, Kassa K, Nagy Z, Kis Z, Simkovits D, Som Z, Csakany L, Major T, Foldesi C. Pulmonary vein isolation for paroxysmal atrial fibrillation using high-power short duration radiofrequency or second-generation cryoballoon ablation. Europace 2021. [DOI: 10.1093/europace/euab116.248] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
Background
Differences in the left atrial (LA) tissue loss can occur following different pulmonary vein isolation (PVI) techniques.
Purpose
Our prospective study compared the biomarker, the LA mechanical, and the electrophysiological findings as indicators of LA myocardial damage after a high-power short duration (HPSD) with contact force radiofrequency catheter and second-generation cryoballoon (CB2) ablation of paroxysmal atrial fibrillation (AF).
Methods :We enrolled 40 patients with paroxysmal AF [16 (40%) women, mean age = 55.9 ± 12.4 years] who underwent HPSD (n = 21) or CB2 (n = 19). Biomarker levels (hs-cTnT, CK-MB, hs-CRP, LDH) and the transport function of the LA by transthoracic echocardiography (TTE) were compared pre and post procedurally. High-density mapping (HDM) was performed in sinus rhythm using a multielectrode diagnostic catheter in each group to define isolated left atrial low voltage area (LVA; <0.2mV in bipolar voltage mapping). LA CT-angiography and HDM merge was used to calculate the post-PVI LVA and the LVA/LA surface ratio.
Results
Postablation hs-cTnT and hs-CRP levels were comparable in the ablation groups (HPSD: 1249 ± 469 and 9.53 ± 10.30 vs. CB2: 995 ± 280 and 12.36 ± 5.76, p = 0.065 and p = 0.732), while CK-MB and LDH levels were significantly higher following CB2 ablation (HPSD: 6.61 ± 2.62 and 349.9 ± 65.6 vs. CB2: 26.01 ± 6.88 and 451.6 ± 91.3, p < 0.001 and p < 0.001). The transport function of the LA did not change significantly by TTE after the procedure. Fractional Area Change at baseline and 3 months was 33.9 ± 13.8 and 33.5 ± 10.7 p = 0.9 in the HPSD group while 38.1 ± 8.6 and 35.3 ± 12.2 p = 0.9 in the CB2 group. LA Ejection Fraction measured in the two groups (before and 3-month post-procedure): HPSD: 51.2 ± 20.5% and 49.5 ± 14.7%, p = 0.9, CB2: 49.7 ± 15.5% and 50.7 ± 13.3%, p = 0.8). Ablation time was comparable in the two groups (HPSD: 1676 ± 570 sec, CB2: 1495 ± 494 sec, p = 0.279), while fluoroscopy time and radiation exposure were significantly higher in the CB2 group (HPSD: 5.62 ± 4.31 min and 232 ± 406 cGycm2, CB2: 13.65 ± 5.18 min and 1819 ± 1669 cGycm2, p <0.001 and p <0.001). The LVA/LA surface ratio were: HPSD group: 8.37 ± 6.42% and CB2 group: 13.58 ± 8.92% (p = 0.007). At 12-month follow-up, the success rate, defined as freedom from AF/atrial tachycardia without antiarrhythmic drug was 80.1% (HPSD) and 84.2% (CB2) respectively.
Conclusions
The LA scar tissue was significantly higher following CB2 ablation, but did not affect medium-term efficacy. However, tissue loss did not reduce the transport function of the LA.
Collapse
Affiliation(s)
- A Kardos
- "Gottsegen Gyorgy" National Institute of Cardiology, Budapest, Hungary
| | - K Kassa
- "Gottsegen Gyorgy" National Institute of Cardiology, Budapest, Hungary
| | - Z Nagy
- "Gottsegen Gyorgy" National Institute of Cardiology, Budapest, Hungary
| | - Z Kis
- "Gottsegen Gyorgy" National Institute of Cardiology, Budapest, Hungary
| | - D Simkovits
- "Gottsegen Gyorgy" National Institute of Cardiology, Budapest, Hungary
| | - Z Som
- "Gottsegen Gyorgy" National Institute of Cardiology, Budapest, Hungary
| | - L Csakany
- "Gottsegen Gyorgy" National Institute of Cardiology, Budapest, Hungary
| | - T Major
- "Gottsegen Gyorgy" National Institute of Cardiology, Budapest, Hungary
| | - C Foldesi
- "Gottsegen Gyorgy" National Institute of Cardiology, Budapest, Hungary
| |
Collapse
|
24
|
Kassa K, Nagy Z, Kesoi B, Som Z, Foldesi C, Kardos A. High-power short-duration radiofrequency ablation for atrial fibrillation. Europace 2021. [DOI: 10.1093/europace/euab116.257] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
Introduction
In recent times, high-power short-duration (HPSD) radiofrequency ablation (RFA) has emerged as an alternative strategy for pulmonary vein isolation (PVI) in atrial fibrillation (AF).
Purpose
We aimed to compare HPSD approach and conventional, ablation-index (AI) guided PVI using contact force sensing ablation catheters in respect of efficacy, safety, procedural characteristics, and outcome.
Methods
A total of 184 consecutive AF patients with first PVI were enrolled (age: 60 ± 11 years, paroxysmal: 56.5%, persistent: 43.5%) between November 2016 and December 2019. An ablation protocol of 50W energy with 15-20 g contact force was used for a duration of 8-12 sec based on the loss of capture concept in the HPSD group (n = 91) meanwhile, PVI was achieved according to the conventional power settings (posterior wall 25W, AI: 400, anterior wall 35W, AI: 550 ) in the control group (n = 93). During 1-year follow-up, documented AF for more than 30 seconds was considered as recurrence.
Results
Radiofrequency time and procedural time were significantly shorter using HPSD ablation (26.0 ± 12.7 min vs. 42.9 ± 12.6 min, p < 0.001, and 91 ± 30.1 min vs. 105.3 ± 28 min, p < 0.001). The HPSD strategy significantly lowered fluoroscopy time and radiation dose (5.47 ± 4.07 min vs. 8.15 ± 10.04 min, p = 0.019, and 430.2 ± 534.06 cGycm2 vs. 604.2 ± 633.9 cGycm2, p = 0.046). The HPSD group showed significantly less arrhythmia recurrence during 1-year follow-up with 76.9% of patients free from AF compared to 66.7% in the control group (p = 0.037). No pericardial tamponade, periprocedural thromboembolic complication, or atrio-oesophageal fistula occurred in the HPSD group. We observed 2 pericardial tamponade and 1 periprocedural stroke in the control group.
Conclusions
HPSD RFA for AF was demonstrated to be safe, and lead to significantly improved 1-year outcome in our mixed patient population. HPSD protocol significantly shortened procedural and radiofrequency time with decreased fluoroscopy time and radiation exposure.
Collapse
Affiliation(s)
- K Kassa
- Semmelweis University, Budapest, Hungary
| | - Z Nagy
- Gottsegen Gy Hungarian Institute Of Cardiolog, Bonyhad, Hungary
| | - B Kesoi
- Gottsegen Gy Hungarian Institute Of Cardiolog, Bonyhad, Hungary
| | - Z Som
- Gottsegen Gy Hungarian Institute Of Cardiolog, Bonyhad, Hungary
| | - C Foldesi
- Gottsegen Gy Hungarian Institute Of Cardiolog, Bonyhad, Hungary
| | - A Kardos
- Gottsegen Gy Hungarian Institute Of Cardiolog, Bonyhad, Hungary
| |
Collapse
|
25
|
Heib T, Hermanns HM, Manukjan G, Englert M, Kusch C, Becker IC, Gerber A, Wackerbarth LM, Burkard P, Dandekar T, Balkenhol J, Jahn D, Beck S, Meub M, Dütting S, Stigloher C, Sauer M, Cherpokova D, Schulze H, Brakebusch C, Nieswandt B, Nagy Z, Pleines I. RhoA/Cdc42 signaling drives cytoplasmic maturation but not endomitosis in megakaryocytes. Cell Rep 2021; 35:109102. [PMID: 33979620 DOI: 10.1016/j.celrep.2021.109102] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2020] [Revised: 02/20/2021] [Accepted: 04/18/2021] [Indexed: 12/15/2022] Open
Abstract
Megakaryocytes (MKs), the precursors of blood platelets, are large, polyploid cells residing mainly in the bone marrow. We have previously shown that balanced signaling of the Rho GTPases RhoA and Cdc42 is critical for correct MK localization at bone marrow sinusoids in vivo. Using conditional RhoA/Cdc42 double-knockout (DKO) mice, we reveal here that RhoA/Cdc42 signaling is dispensable for the process of polyploidization in MKs but essential for cytoplasmic MK maturation. Proplatelet formation is virtually abrogated in the absence of RhoA/Cdc42 and leads to severe macrothrombocytopenia in DKO animals. The MK maturation defect is associated with downregulation of myosin light chain 2 (MLC2) and β1-tubulin, as well as an upregulation of LIM kinase 1 and cofilin-1 at both the mRNA and protein level and can be linked to impaired MKL1/SRF signaling. Our findings demonstrate that MK endomitosis and cytoplasmic maturation are separately regulated processes, and the latter is critically controlled by RhoA/Cdc42.
Collapse
Affiliation(s)
- Tobias Heib
- Institute of Experimental Biomedicine, University Hospital, University of Würzburg, 97080 Würzburg, Germany; Rudolf Virchow Center, University of Würzburg, 97080 Würzburg, Germany
| | - Heike M Hermanns
- Department of Internal Medicine II, Hepatology Research Laboratory, University Hospital Würzburg, 97080 Würzburg, Germany
| | - Georgi Manukjan
- Institute of Experimental Biomedicine, University Hospital, University of Würzburg, 97080 Würzburg, Germany; Rudolf Virchow Center, University of Würzburg, 97080 Würzburg, Germany
| | - Maximilian Englert
- Institute of Experimental Biomedicine, University Hospital, University of Würzburg, 97080 Würzburg, Germany; Rudolf Virchow Center, University of Würzburg, 97080 Würzburg, Germany
| | - Charly Kusch
- Institute of Experimental Biomedicine, University Hospital, University of Würzburg, 97080 Würzburg, Germany; Rudolf Virchow Center, University of Würzburg, 97080 Würzburg, Germany
| | - Isabelle Carlotta Becker
- Institute of Experimental Biomedicine, University Hospital, University of Würzburg, 97080 Würzburg, Germany; Rudolf Virchow Center, University of Würzburg, 97080 Würzburg, Germany
| | - Annika Gerber
- Institute of Experimental Biomedicine, University Hospital, University of Würzburg, 97080 Würzburg, Germany; Rudolf Virchow Center, University of Würzburg, 97080 Würzburg, Germany
| | - Lou Martha Wackerbarth
- Institute of Experimental Biomedicine, University Hospital, University of Würzburg, 97080 Würzburg, Germany; Rudolf Virchow Center, University of Würzburg, 97080 Würzburg, Germany
| | - Philipp Burkard
- Institute of Experimental Biomedicine, University Hospital, University of Würzburg, 97080 Würzburg, Germany; Rudolf Virchow Center, University of Würzburg, 97080 Würzburg, Germany
| | - Thomas Dandekar
- Department of Bioinformatics, Biocenter, University of Würzburg, 97074 Würzburg, Germany
| | - Johannes Balkenhol
- Department of Internal Medicine II, Hepatology Research Laboratory, University Hospital Würzburg, 97080 Würzburg, Germany; Department of Bioinformatics, Biocenter, University of Würzburg, 97074 Würzburg, Germany
| | - Daniel Jahn
- Department of Internal Medicine II, Hepatology Research Laboratory, University Hospital Würzburg, 97080 Würzburg, Germany
| | - Sarah Beck
- Institute of Experimental Biomedicine, University Hospital, University of Würzburg, 97080 Würzburg, Germany; Rudolf Virchow Center, University of Würzburg, 97080 Würzburg, Germany
| | - Mara Meub
- Department of Biotechnology and Biophysics, Biocenter, University of Würzburg, 97074 Würzburg, Germany
| | - Sebastian Dütting
- Institute of Experimental Biomedicine, University Hospital, University of Würzburg, 97080 Würzburg, Germany; Rudolf Virchow Center, University of Würzburg, 97080 Würzburg, Germany
| | - Christian Stigloher
- Imaging Core Facility, Biocenter, University of Würzburg, 97074 Würzburg, Germany
| | - Markus Sauer
- Department of Biotechnology and Biophysics, Biocenter, University of Würzburg, 97074 Würzburg, Germany
| | - Deya Cherpokova
- Institute of Experimental Biomedicine, University Hospital, University of Würzburg, 97080 Würzburg, Germany; Rudolf Virchow Center, University of Würzburg, 97080 Würzburg, Germany
| | - Harald Schulze
- Institute of Experimental Biomedicine, University Hospital, University of Würzburg, 97080 Würzburg, Germany; Rudolf Virchow Center, University of Würzburg, 97080 Würzburg, Germany
| | - Cord Brakebusch
- Biotech Research and Innovation Centre (BRIC), University of Copenhagen, 2200 Copenhagen, Denmark
| | - Bernhard Nieswandt
- Institute of Experimental Biomedicine, University Hospital, University of Würzburg, 97080 Würzburg, Germany; Rudolf Virchow Center, University of Würzburg, 97080 Würzburg, Germany.
| | - Zoltan Nagy
- Institute of Experimental Biomedicine, University Hospital, University of Würzburg, 97080 Würzburg, Germany; Rudolf Virchow Center, University of Würzburg, 97080 Würzburg, Germany
| | - Irina Pleines
- Institute of Experimental Biomedicine, University Hospital, University of Würzburg, 97080 Würzburg, Germany; Rudolf Virchow Center, University of Würzburg, 97080 Würzburg, Germany.
| |
Collapse
|
26
|
Mukli P, Nagy Z, Racz FS, Portoro I, Hartmann A, Stylianou O, Debreczeni R, Bereczki D, Eke A. Corrigendum: Two-Tiered Response of Cardiorespiratory-Cerebrovascular Network to Orthostatic Challenge. Front Physiol 2021; 12:685417. [PMID: 33967839 PMCID: PMC8098711 DOI: 10.3389/fphys.2021.685417] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2021] [Accepted: 04/01/2021] [Indexed: 12/03/2022] Open
Affiliation(s)
- Peter Mukli
- Department of Physiology, Semmelweis University, Budapest, Hungary.,Vascular Cognitive Impairment and Neurodegeneration Program, Oklahoma Center for Geroscience and Healthy Brain Aging, Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.,Institute of Translational Medicine, Semmelweis University, Budapest, Hungary
| | - Zoltan Nagy
- Institute of Translational Medicine, Semmelweis University, Budapest, Hungary
| | | | - Istvan Portoro
- Institute of Translational Medicine, Semmelweis University, Budapest, Hungary
| | - Andras Hartmann
- Institute of Translational Medicine, Semmelweis University, Budapest, Hungary.,Institute for Globally Distributed Open Research and Education (IGDORE), Stockholm, Sweden
| | - Orestis Stylianou
- Department of Physiology, Semmelweis University, Budapest, Hungary.,Institute of Translational Medicine, Semmelweis University, Budapest, Hungary
| | | | - Daniel Bereczki
- Department of Neurology, Semmelweis University, Budapest, Hungary
| | - Andras Eke
- Department of Physiology, Semmelweis University, Budapest, Hungary.,Institute of Translational Medicine, Semmelweis University, Budapest, Hungary.,Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, CT, United States
| |
Collapse
|
27
|
Stavnichuk M, Tauer JT, Nagy Z, Mazharian A, Welman M, Lordkipanidzé M, Senis YA, Komarova SV. Severity of Megakaryocyte-Driven Osteosclerosis in Mpig6b-Deficient Mice Is Sex-Linked. J Bone Miner Res 2021; 36:803-813. [PMID: 33434328 DOI: 10.1002/jbmr.4245] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/01/2020] [Revised: 12/16/2020] [Accepted: 12/29/2020] [Indexed: 01/15/2023]
Abstract
Patients with chronic myelofibrosis often suffer from osteosclerosis, which is associated with bone pain and may lead to bone marrow failure. The pathogenesis of myelofibrosis is linked to aberrant megakaryocyte development and function. Null and loss-of-function mutations in MPIG6B, which codes for the inhibitory heparan sulfate receptor G6b-B, result in severe macrothrombocytopenia, large megakaryocyte clusters, and focal primary myelofibrosis in mice and humans. We investigated the development of osteosclerosis in Mpig6b null (Mpig6b-/- ) mice. Although male and female Mpig6b-/- mice presented with elevated bone marrow megakaryocyte number and macrothrombocytopenia, female Mpig6b-/- mice developed progressive splenomegaly starting at 8 weeks of age. Micro-computed tomography (μCT) of femurs showed that female Mpig6b-/- mice had increased cortical thickness and reduced bone marrow area starting at 8 weeks of age and developed occlusion of the medullary cavity by trabeculae by 16 weeks of age. In contrast, male Mpig6b-/- mice developed only a small number of trabeculae in the medullary cavity at the proximal diaphysis and demonstrated a temporary decrease in bone volume fraction and trabecular thickness at 16 weeks. Ovariectomy of 10-week-old female Mpig6b-/- mice prevented the development of medullary cavity osteosclerosis, whereas orchiectomy of male Mpig6b-/- mice did not exacerbate their disease. Importantly, ovariectomized female Mpig6b-/- mice also demonstrated improvement in spleen weight compared to sham-operated Mpig6b-/- mice, establishing estrogen as a contributing factor to the severity of the megakaryocyte-driven osteosclerosis. © 2021 American Society for Bone and Mineral Research (ASBMR).
Collapse
Affiliation(s)
- Mariya Stavnichuk
- Department of Biological and Biomedical Engineering, McGill University, Montreal, QC, Canada.,Shriners Hospital for Children-Canada, Montreal, QC, Canada
| | - Josephine T Tauer
- Shriners Hospital for Children-Canada, Montreal, QC, Canada.,Faculty of Dentistry, McGill University, Montreal, QC, Canada
| | - Zoltan Nagy
- Institute of Experimental Biomedicine, University Hospital and Rudolf Virchow Center, University of Würzburg, Würzburg, Germany
| | - Alexandra Mazharian
- Université de Strasbourg, Institut National de la Santé et de la Recherche Médicale (INSERM), Etablissement Français du Sang Grand Est, Unité Mixte de Recherche (UMR)-S 1255, Fédération de Médecine Translationnelle de Strasbourg, Strasbourg, France
| | - Mélanie Welman
- Research Center, Montreal Heart Institute, Montreal, QC, Canada
| | - Marie Lordkipanidzé
- Research Center, Montreal Heart Institute, Montreal, QC, Canada.,Faculty of Pharmacy, University of Montreal, Montreal, QC, Canada
| | - Yotis A Senis
- Université de Strasbourg, Institut National de la Santé et de la Recherche Médicale (INSERM), Etablissement Français du Sang Grand Est, Unité Mixte de Recherche (UMR)-S 1255, Fédération de Médecine Translationnelle de Strasbourg, Strasbourg, France
| | - Svetlana V Komarova
- Department of Biological and Biomedical Engineering, McGill University, Montreal, QC, Canada.,Shriners Hospital for Children-Canada, Montreal, QC, Canada.,Faculty of Dentistry, McGill University, Montreal, QC, Canada
| |
Collapse
|
28
|
Darányi V, Hermann P, Homolya I, Vidnyánszky Z, Nagy Z. An empirical investigation of the benefit of increasing the temporal resolution of task-evoked fMRI data with multi-band imaging. MAGMA 2021; 34:667-676. [PMID: 33763764 PMCID: PMC8421273 DOI: 10.1007/s10334-021-00918-z] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/11/2020] [Revised: 02/26/2021] [Accepted: 03/03/2021] [Indexed: 11/24/2022]
Abstract
Objective There is a tendency for reducing TR in MRI experiments with multi-band imaging. We empirically investigate its benefit for the group-level statistical outcome in task-evoked fMRI. Methods Three visual fMRI data sets were collected from 17 healthy adult participants. Multi-band acquisition helped vary the TR (2000/1000/410 ms, respectively). Because these data sets capture different temporal aspects of the haemodynamic response (HRF), we tested several HRF models. We computed a composite descriptive statistic, H, from β’s of each first-level model fit and carried it to the group-level analysis. The number of activated voxels and the t value of the group-level analysis as well as a goodness-of-fit measure were used as surrogate markers of data quality for comparison. Results Increasing the temporal sampling rate did not provide a universal improvement in the group-level statistical outcome. Rather, both the voxel-wise and ROI-averaged group-level results varied widely with anatomical location, choice of HRF and the setting of the TR. Correspondingly, the goodness-of-fit of HRFs became worse with increasing the sampling frequency. Conclusion Rather than universally increasing the temporal sampling rate in cognitive fMRI experiments, these results advocate the performance of a pilot study for the specific ROIs of interest to identify the appropriate temporal sampling rate for the acquisition and the correspondingly suitable HRF for the analysis of the data. Supplementary Information The online version contains supplementary material available at 10.1007/s10334-021-00918-z.
Collapse
Affiliation(s)
- Virág Darányi
- Brain Imaging Centre, Research Centre for Natural Sciences, Budapest, Hungary
| | - Petra Hermann
- Brain Imaging Centre, Research Centre for Natural Sciences, Budapest, Hungary
| | - István Homolya
- Brain Imaging Centre, Research Centre for Natural Sciences, Budapest, Hungary
| | - Zoltán Vidnyánszky
- Brain Imaging Centre, Research Centre for Natural Sciences, Budapest, Hungary
| | - Zoltan Nagy
- Laboratory for Social and Neural Systems Research, University of Zürich, Rämistrasse 100, P.O. Box 149, Zürich, Switzerland.
| |
Collapse
|
29
|
Senis YA, Nagy Z, Mori J, Lane S, Lane P. Platelet Src family kinases: A tale of reversible phosphorylation. Res Pract Thromb Haemost 2021; 5:376-389. [PMID: 33870023 PMCID: PMC8035799 DOI: 10.1002/rth2.12495] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2020] [Revised: 01/17/2021] [Accepted: 01/19/2021] [Indexed: 11/07/2022] Open
Abstract
Sarcoma (Src) family kinases (SFKs) have occupied a central place in platelet research for over 40 years. Discovered by virologists and oncologists as the proto proto-oncogene, Src tyrosine kinase spurred a phenomenal burst of research on reversible tyrosine phosphorylation and signal transduction. For a time, platelets were adopted as the model of choice for studying the biological functions of Src, owing to their ease of isolation, high Src expression, and lack of a nucleus, only to be abandoned due to challenges of culturing and manipulating using common molecular biology-based techniques. For platelet biologists, SFKs have remained an important area of investigation, initiating and amplifying signals from all major adhesion, activation, and inhibitory receptors, including the integrin αIIbβ3, the collagen receptor complex glycoprotein VI-Fc receptor γ-chain, the G protein-coupled ADP receptor P2Y12 and the inhibitory receptors platelet endothelial cell adhesion molecule-1 and G6b-B. The vital roles of SFKs in platelets is highlighted by the severe phenotypes of null and gain-of-function mutations in SFKs in mice and humans, and effects of pharmacologic inhibitors on platelet activation, thrombosis, and hemostasis. The recent description of critical regulators of SFKs in platelets, namely, C-terminal Src kinase (Csk), Csk homologous kinase (Chk), the receptor-type protein-tyrosine phosphatase receptor type J (PTPRJ) helps explain some of the bleeding side effects of tyrosine kinase inhibitors and are novel therapeutic targets for regulating the thrombotic and hemostatic capacity of platelets. Recent findings from Chk, Csk, and PTPRJ knockout mouse models highlighted that SFKs are able to autoinhibit by phosphorylating their C-terminal tyrosine residues, providing fundamental insights into SFK autoregulation.
Collapse
Affiliation(s)
- Yotis A Senis
- Unité Mixte de Recherche-S 1255 Fédération de Médecine Translationnelle de Strasbourg Université de Strasbourg Institut National de la Santé et de la Recherche Médicale Etablissement Français du Sang Grand Est Strasbourg France
| | - Zoltan Nagy
- Institute of Experimental Biomedicine University Hospital and Rudolf Virchow Center University of Würzburg Würzburg Germany
| | - Jun Mori
- Research and Development Align Technology Inc. Yokohama Japan
| | - Sophia Lane
- Illustration and Design, ScEYEnce Studios Elkins Park PA USA
| | - Patrick Lane
- Illustration and Design, ScEYEnce Studios Elkins Park PA USA
| |
Collapse
|
30
|
Mukli P, Nagy Z, Racz FS, Portoro I, Hartmann A, Stylianou O, Debreczeni R, Bereczki D, Eke A. Two-Tiered Response of Cardiorespiratory-Cerebrovascular Network to Orthostatic Challenge. Front Physiol 2021; 12:622569. [PMID: 33737882 PMCID: PMC7960776 DOI: 10.3389/fphys.2021.622569] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2020] [Accepted: 02/08/2021] [Indexed: 12/23/2022] Open
Abstract
Dynamic interdependencies within and between physiological systems and subsystems are key for homeostatic mechanisms to establish an optimal state of the organism. These interactions mediate regulatory responses elicited by various perturbations, such as the high-pressure baroreflex and cerebral autoregulation, alleviating the impact of orthostatic stress on cerebral hemodynamics and oxygenation. The aim of this study was to evaluate the responsiveness of the cardiorespiratory-cerebrovascular networks by capturing linear and nonlinear interdependencies to postural changes. Ten young healthy adults participated in our study. Non-invasive measurements of arterial blood pressure (from that cardiac cycle durations were derived), breath-to-breath interval, cerebral blood flow velocity (BFV, recorded by transcranial Doppler sonography), and cerebral hemodynamics (HbT, total hemoglobin content monitored by near-infrared spectroscopy) were performed for 30-min in resting state, followed by a 1-min stand-up and a 1-min sit-down period. During preprocessing, noise was filtered and the contribution of arterial blood pressure was regressed from BFV and HbT signals. Cardiorespiratory-cerebrovascular networks were reconstructed by computing pair-wise Pearson-correlation or mutual information between the resampled signals to capture their linear and/or nonlinear interdependencies, respectively. The interdependencies between cardiac, respiratory, and cerebrovascular dynamics showed a marked weakening after standing up persisting throughout the sit-down period, which could mainly be attributed to strikingly attenuated nonlinear coupling. To summarize, we found that postural changes induced topological changes in the cardiorespiratory-cerebrovascular network. The dissolution of nonlinear networks suggests that the complexity of key homeostatic mechanisms maintaining cerebral hemodynamics and oxygenation is indeed sensitive to physiological perturbations such as orthostatic stress.
Collapse
Affiliation(s)
- Peter Mukli
- Department of Physiology, Semmelweis University, Budapest, Hungary.,Vascular Cognitive Impairment and Neurodegeneration Program, Oklahoma Center for Geroscience and Healthy Brain Aging, Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.,Institute of Translational Medicine, Semmelweis University, Budapest, Hungary
| | - Zoltan Nagy
- Institute of Translational Medicine, Semmelweis University, Budapest, Hungary
| | | | - Istvan Portoro
- Institute of Translational Medicine, Semmelweis University, Budapest, Hungary
| | - Andras Hartmann
- Institute of Translational Medicine, Semmelweis University, Budapest, Hungary.,Institute for Globally Distributed Open Research and Education (IGDORE), Stockholm, Sweden
| | - Orestis Stylianou
- Department of Physiology, Semmelweis University, Budapest, Hungary.,Institute of Translational Medicine, Semmelweis University, Budapest, Hungary
| | | | - Daniel Bereczki
- Department of Neurology, Semmelweis University, Budapest, Hungary
| | - Andras Eke
- Department of Physiology, Semmelweis University, Budapest, Hungary.,Institute of Translational Medicine, Semmelweis University, Budapest, Hungary.,Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, CT, United States
| |
Collapse
|
31
|
Ganepola T, Lee Y, Alexander DC, Sereno MI, Nagy Z. Multiple b-values improve discrimination of cortical gray matter regions using diffusion MRI: an experimental validation with a data-driven approach. MAGMA 2021; 34:677-687. [PMID: 33709225 PMCID: PMC8421285 DOI: 10.1007/s10334-021-00914-3] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/21/2020] [Revised: 12/14/2020] [Accepted: 02/04/2021] [Indexed: 11/28/2022]
Abstract
Objective To investigate whether varied or repeated b-values provide better diffusion MRI data for discriminating cortical areas with a data-driven approach. Methods Data were acquired from three volunteers at 1.5T with b-values of 800, 1400, 2000 s/mm2 along 64 diffusion-encoding directions. The diffusion signal was sampled from gray matter in seven regions of interest (ROIs). Rotational invariants of the local diffusion profile were extracted as features that characterize local tissue properties. Random forest classification experiments assessed whether classification accuracy improved when data with multiple b-values were used over repeated acquisition of the same (1400 s/mm2) b-value to compare all possible pairs of the seven ROIs. Three data sets from the Human Connectome Project were subjected to similar processing and analysis pipelines in eight ROIs. Results Three different b-values showed an average improvement in correct classification rates of 5.6% and 4.6%, respectively, in the local and HCP data over repeated measurements of the same b-value. The improvement in correct classification rate reached as high as 16% for individual binary classification experiments between two ROIs. Often using only two of the available three b-values were adequate to make such an improvement in classification rates. Conclusion Acquisitions with varying b-values are more suitable for discriminating cortical areas.
Collapse
Affiliation(s)
- Tara Ganepola
- Department of Cognitive, Perceptual and Brain Sciences, University College London, London, UK.,Center for Medical Image Computing, Department of Computer Science, University College London, London, UK
| | - Yoojin Lee
- Laboratory for Social and Neural Systems Research, University of Zurich, Rämistrasse 100, P.O. Box 149, Zurich, Switzerland.,Institute of Biomedical Engineering, ETH Zurich, Zurich, Switzerland
| | - Daniel C Alexander
- Center for Medical Image Computing, Department of Computer Science, University College London, London, UK
| | - Martin I Sereno
- Department of Cognitive, Perceptual and Brain Sciences, University College London, London, UK.,Department of Psychology and Neuroimaging Centre, SDSU, San Diego, USA
| | - Zoltan Nagy
- Laboratory for Social and Neural Systems Research, University of Zurich, Rämistrasse 100, P.O. Box 149, Zurich, Switzerland. .,Wellcome Trust Centre for Neuroimaging, UCL Institute of Neurology, London, UK.
| |
Collapse
|
32
|
|
33
|
Lee Y, Wilm BJ, Brunner DO, Gross S, Schmid T, Nagy Z, Pruessmann KP. On the signal-to-noise ratio benefit of spiral acquisition in diffusion MRI. Magn Reson Med 2020; 85:1924-1937. [PMID: 33280160 DOI: 10.1002/mrm.28554] [Citation(s) in RCA: 18] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2020] [Revised: 09/15/2020] [Accepted: 09/22/2020] [Indexed: 12/20/2022]
Abstract
PURPOSE Spiral readouts combine several favorable properties that promise superior net sensitivity for diffusion imaging. The purpose of this study is to verify the signal-to-noise ratio (SNR) benefit of spiral acquisition in comparison with current echo-planar imaging (EPI) schemes. METHODS Diffusion-weighted in vivo brain data from three subjects were acquired with a single-shot spiral sequence and several variants of single-shot EPI, including full-Fourier and partial-Fourier readouts as well as different diffusion-encoding schemes. Image reconstruction was based on an expanded signal model including field dynamics obtained by concurrent field monitoring. The effective resolution of each sequence was matched to that of full-Fourier EPI with 1 mm nominal resolution. SNR maps were generated by determining the noise statistics of the raw data and analyzing the propagation of equivalent synthetic noise through image reconstruction. Using the same approach, maps of noise amplification due to parallel imaging (g-factor) were calculated for different acceleration factors. RESULTS Relative to full-Fourier EPI at b = 0 s/mm2 , spiral acquisition yielded SNR gains of 42-88% and 40-89% in white and gray matter, respectively, depending on the diffusion-encoding scheme. Relative to partial-Fourier EPI, the gains were 36-44% and 34-42%. Spiral g-factor maps exhibited less spatial variation and lower maxima than their EPI counterparts. CONCLUSION Spiral readouts achieve significant SNR gains in the order of 40-80% over EPI in diffusion imaging at 3T. Combining systematic effects of shorter echo time, readout efficiency, and favorable g-factor behavior, similar benefits are expected across clinical and neurosciences uses of diffusion imaging.
Collapse
Affiliation(s)
- Yoojin Lee
- Institute for Biomedical Engineering, ETH Zurich and University of Zurich, Zurich, Switzerland.,Laboratory for Social and Neural Systems Research, University of Zurich, Zurich, Switzerland
| | - Bertram J Wilm
- Institute for Biomedical Engineering, ETH Zurich and University of Zurich, Zurich, Switzerland
| | - David O Brunner
- Institute for Biomedical Engineering, ETH Zurich and University of Zurich, Zurich, Switzerland
| | - Simon Gross
- Institute for Biomedical Engineering, ETH Zurich and University of Zurich, Zurich, Switzerland
| | - Thomas Schmid
- Institute for Biomedical Engineering, ETH Zurich and University of Zurich, Zurich, Switzerland
| | - Zoltan Nagy
- Laboratory for Social and Neural Systems Research, University of Zurich, Zurich, Switzerland
| | - Klaas P Pruessmann
- Institute for Biomedical Engineering, ETH Zurich and University of Zurich, Zurich, Switzerland
| |
Collapse
|
34
|
Olah A, Matyas C, Barta B, Sayour A, Ruppert M, Braun S, Kovacs A, Merkely B, Nagy Z, Radovits T, Nardai S. Cardiac functional consequences of stroke induced by transient middle cerebral artery occlusion in a rodent model. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.3144] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
The cardiac functional consequences of ischaemic stroke are still need to be elucidated, while according to ethical issues only non-inasive measurents were carried out in patients underwent transient cerebral ischaemia.
Purpose
We aimed at investigating left ventricular function using non-invasive and invasive modalities in a rat model of transient focal ischaemia.
Methods
Age-matched, young adult rats were used for this study. Serial left ventricular echocardiographic measurements and speckle-tracking analysis were performed in rats (n=9) underwent transient middle cerebral artery occlusion (MCAO) before, during and immediately after the induction of stroke, with a follow-up at 24, 48, 72 hours; 7, 11 and 14 days. In another experimental setting, 48 hours after stroke induction (MCAO group, n=9) we characterized left ventricular function by pressure-volume analysis, that was compared to sham-operated controls (Co group, n=9).
Results
Serial echocardiographic measurements showed impaired systolic function, that was most severe 48 hours after MCAO (global circumferential strain, GCS: −14.8±2.6% 48 hours after MCAO vs. −19.3±2.4% baseline, p<0.05). A complete recovery of systolic functional deterioration was observed after 14 days (GCS: −19.2±2.5% 14 days after MCAO vs. −19.3±2.4% baseline, n.s.). Heart weight (normalized to tibial weight) did not differ between MCAO and Co animals. Pressure-volume analysis revealed unaltered diastolic function and showed unchanged load-independent contractility index values (slope of end-systolic pressure-volume relationship, ESPVR: 2.56±0.29mmHg/μl MCAO vs. 2.55±0.59 mmHg/μl Co, n.s.) after MCAO. There was a tendency towards increased systolic pressure and deteriorated ventriculo-arterial coupling in animals underwent stroke.
Conclusions
Our data suggests that MCAO is associated with reversible impairment of systolic function during echocardiographic measurements, however without alteration of intrinsic myocardial contractility. The tendency towards increased afterload might explain the observed alterations in rats underwent stroke.
Funding Acknowledgement
Type of funding source: None
Collapse
Affiliation(s)
- A Olah
- Semmelweis University, Heart and Vascular Center, Budapest, Hungary
| | - C Matyas
- Semmelweis University, Heart and Vascular Center, Budapest, Hungary
| | - B.A Barta
- Semmelweis University, Heart and Vascular Center, Budapest, Hungary
| | - A.A Sayour
- Semmelweis University, Heart and Vascular Center, Budapest, Hungary
| | - M Ruppert
- Semmelweis University, Heart and Vascular Center, Budapest, Hungary
| | - S Braun
- Semmelweis University, Heart and Vascular Center, Budapest, Hungary
| | - A Kovacs
- Semmelweis University, Heart and Vascular Center, Budapest, Hungary
| | - B Merkely
- Semmelweis University, Heart and Vascular Center, Budapest, Hungary
| | - Z Nagy
- National Institute of Clinical Neurosciences, Budapest, Hungary
| | - T Radovits
- Semmelweis University, Heart and Vascular Center, Budapest, Hungary
| | - S Nardai
- Semmelweis University, Heart and Vascular Center, Budapest, Hungary
| |
Collapse
|
35
|
Comer S, Nagy Z, Bolado A, von Kriegsheim A, Gambaryan S, Walter U, Pagel O, Zahedi RP, Jurk K, Smolenski A. The RhoA regulators Myo9b and GEF-H1 are targets of cyclic nucleotide-dependent kinases in platelets. J Thromb Haemost 2020; 18:3002-3012. [PMID: 32692911 DOI: 10.1111/jth.15028] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2020] [Revised: 06/15/2020] [Accepted: 07/13/2020] [Indexed: 12/18/2022]
Abstract
BACKGROUND Circulating platelets are maintained in an inactive state by the endothelial lining of the vasculature. Endothelium-derived prostacyclin and nitric oxide stimulate cAMP- and cGMP-dependent kinases, PKA and PKG, to inhibit platelets. PKA and PKG effects include the inhibition of the GTPase RhoA, which has been suggested to involve the direct phosphorylation of RhoA on serine 188. OBJECTIVES We wanted to confirm RhoA S188 phosphorylation by cyclic nucleotide-dependent kinases and to identify possible alternative mechanisms of RhoA regulation in platelets. METHODS Phosphoproteomics data of human platelets were used to identify candidate PKA and PKG substrates. Phosphorylation of individual proteins was studied by Western blotting and Phos-tag gel electrophoresis in human platelets and transfected HEK293T cells. Pull-down assays were performed to analyze protein interaction and function. RESULTS Our data indicate that RhoA is not phosphorylated by PKA in platelets. Instead, we provide evidence that cyclic nucleotide effects are mediated through the phosphorylation of the RhoA-specific GTPase-activating protein Myo9b and the guanine nucleotide exchange factor GEF-H1. We identify Myo9b S1354 and guanine nucleotide exchange factor-H1 (GEF-H1) S886 as PKA and PKG phosphorylation sites. Myo9b S1354 phosphorylation enhances its GTPase activating protein function leading to reduced RhoA-GTP levels. GEF-H1 S886 phosphorylation stimulates binding of 14-3-3β and has been shown to inhibit GEF function by facilitating binding of GEF-H1 to microtubules. Microtubule disruption increases RhoA-GTP levels confirming the importance of GEF-H1 in platelets. CONCLUSION Phosphorylation of RhoA regulatory proteins Myo9b and GEF-H1, but not RhoA itself, is involved in cyclic nucleotide-mediated control of RhoA in human platelets.
Collapse
Affiliation(s)
- Shane Comer
- UCD School of Medicine and Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland
- Irish Centre for Vascular Biology, Royal College of Surgeons in Ireland, Dublin 2, Ireland
| | - Zoltan Nagy
- UCD School of Medicine and Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland
- Institute of Experimental Biomedicine, University Hospital and Rudolf Virchow Center, University of Würzburg, Würzburg, Germany
| | - Alfonso Bolado
- Cancer Research UK Edinburgh Centre, University of Edinburgh, Edinburgh, UK
| | | | - Stepan Gambaryan
- Sechenov Institute for Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, St. Petersburg, Russia
| | - Ulrich Walter
- Center for Thrombosis and Hemostasis, University Medical Center Mainz, Mainz, Germany
| | - Oliver Pagel
- Leibniz-Institut für Analytische Wissenschaften-ISAS-e.V., Dortmund, Germany
| | - René P Zahedi
- Leibniz-Institut für Analytische Wissenschaften-ISAS-e.V., Dortmund, Germany
- Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC, Canada
| | - Kerstin Jurk
- Center for Thrombosis and Hemostasis, University Medical Center Mainz, Mainz, Germany
| | - Albert Smolenski
- UCD School of Medicine and Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland
- Irish Centre for Vascular Biology, Royal College of Surgeons in Ireland, Dublin 2, Ireland
| |
Collapse
|
36
|
Miller C, Kathirgamanathan A, Picchetti B, Arjunan P, Park JY, Nagy Z, Raftery P, Hobson BW, Shi Z, Meggers F. The Building Data Genome Project 2, energy meter data from the ASHRAE Great Energy Predictor III competition. Sci Data 2020; 7:368. [PMID: 33110076 PMCID: PMC7591488 DOI: 10.1038/s41597-020-00712-x] [Citation(s) in RCA: 32] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2020] [Accepted: 09/29/2020] [Indexed: 12/05/2022] Open
Abstract
This paper describes an open data set of 3,053 energy meters from 1,636 non-residential buildings with a range of two full years (2016 and 2017) at an hourly frequency (17,544 measurements per meter resulting in approximately 53.6 million measurements). These meters were collected from 19 sites across North America and Europe, with one or more meters per building measuring whole building electrical, heating and cooling water, steam, and solar energy as well as water and irrigation meters. Part of these data was used in the Great Energy Predictor III (GEPIII) competition hosted by the American Society of Heating, Refrigeration, and Air-Conditioning Engineers (ASHRAE) in October-December 2019. GEPIII was a machine learning competition for long-term prediction with an application to measurement and verification. This paper describes the process of data collection, cleaning, and convergence of time-series meter data, the meta-data about the buildings, and complementary weather data. This data set can be used for further prediction benchmarking and prototyping as well as anomaly detection, energy analysis, and building type classification.
Collapse
Affiliation(s)
- Clayton Miller
- Building and Urban Data Science (BUDS) Lab, School of Design and Environment (SDE), National University of Singapore (NUS), 4 Architecture Drive, Singapore, 117566, Singapore.
| | - Anjukan Kathirgamanathan
- UCD Energy Institute, O'Brien Science Building, University College Dublin, Belfield, Dublin, D04 V1W8, Ireland
| | - Bianca Picchetti
- Gerencia del Ciclo de Combustible Nuclear, Comisión Nacional de Energía Atómica, Avenida General Paz 1499, Buenos Aires, 1650, Argentina
| | - Pandarasamy Arjunan
- Berkeley Education Alliance for Research in Singapore (BEARS), 1 Create Way, #11-01, CREATE Tower, Singapore, 138602, Singapore
| | - June Young Park
- Intelligent Environments Lab (IEL), Department of Civil, Architectural and Environmental Engineering, Cockrell School of Engineering, The University of Texas at Austin, 301 E Dean Keeton Street St C1700, Austin, TX, 78712, USA
| | - Zoltan Nagy
- Intelligent Environments Lab (IEL), Department of Civil, Architectural and Environmental Engineering, Cockrell School of Engineering, The University of Texas at Austin, 301 E Dean Keeton Street St C1700, Austin, TX, 78712, USA
| | - Paul Raftery
- Center for the Built Environment, University of California, 390 Wurster Hall, Berkeley, CA, 94720, USA
| | - Brodie W Hobson
- Department of Civil and Environmental Engineering, Carleton University, 1125 Colonel By Drive, Ottawa, ON, K1S 5B6, Canada
| | - Zixiao Shi
- Department of Civil and Environmental Engineering, Carleton University, 1125 Colonel By Drive, Ottawa, ON, K1S 5B6, Canada
| | - Forrest Meggers
- CHAOS Laboratory, School of Architecture, Princeton University, 86 Olden St, Princeton, NJ, 08540, USA
| |
Collapse
|
37
|
Czigléczki G, Nagy Z, Padányi C, Banczerowski P. Biportal endoscopic technique in the treatment of spinal stenosis: early clinical experiences and results. Neurol Res 2020; 42:1085-1088. [PMID: 32892719 DOI: 10.1080/01616412.2020.1803603] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
OBJECTIVE Minimally invasive procedures in spine surgery have undergone significant development in recent times. A demand emerged from both surgeons and patients to develop and perform these types of surgeries in order to prevent biomechanical and surgical complications. Our study aimed to present early clinical results of a biportal endoscopy technique in the treatment of degenerative spinal stenosis. METHOD We created a retrospective database of patients who underwent biportal spinal endoscopic decompression at the National Institute of Clinical Neuroscience, Department of Neurosurgery, Semmelweis University, Budapest, Hungary, in 2019. The surgical steps of technique is discussed in details. RESULTS Retrospectively, we identified and collected 21 patients in our retrospective analysis. The early results after endoscopic decompression were excellent, 17 patients (81%) mentioned good general comfort which coincided with small incisions and the preservation of posterior spinal muscles. Three patients (14%) mentioned good condition and minor postoperative pain which could be controlled with analgesics. One patients (5%) mentioned postoperative discomfort. The patients were controlled at 3, 6 and 9 months. The mean follow-up time was 7 months. DISCUSSION Biportal endoscopic technique was developed to fulfil the requirements of minimally invasive techniques. Our results indicate this method may be highly effective for the treatment of lumbar spinal stenosis and an alternative to conventional microsurgical decompression; however, our study limited by its retrospective manner and small population size.
Collapse
Affiliation(s)
- Gábor Czigléczki
- Department of Spinal Surgery, National Institute of Clinical Neurosciences , Budapest, Hungary.,Department of Neurosurgery, Semmelweis University , Budapest, Hungary
| | - Zoltan Nagy
- Department of Spinal Surgery, National Institute of Clinical Neurosciences , Budapest, Hungary.,Department of Neurosurgery, Semmelweis University , Budapest, Hungary
| | - Csaba Padányi
- Department of Spinal Surgery, National Institute of Clinical Neurosciences , Budapest, Hungary
| | - Péter Banczerowski
- Department of Spinal Surgery, National Institute of Clinical Neurosciences , Budapest, Hungary.,Department of Neurosurgery, Semmelweis University , Budapest, Hungary
| |
Collapse
|
38
|
Diaconescu AO, Stecy M, Kasper L, Burke CJ, Nagy Z, Mathys C, Tobler PN. Neural arbitration between social and individual learning systems. eLife 2020; 9:54051. [PMID: 32779568 PMCID: PMC7476763 DOI: 10.7554/elife.54051] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2019] [Accepted: 08/10/2020] [Indexed: 12/20/2022] Open
Abstract
Decision making requires integrating knowledge gathered from personal experiences with advice from others. The neural underpinnings of the process of arbitrating between information sources has not been fully elucidated. In this study, we formalized arbitration as the relative precision of predictions, afforded by each learning system, using hierarchical Bayesian modeling. In a probabilistic learning task, participants predicted the outcome of a lottery using recommendations from a more informed advisor and/or self-sampled outcomes. Decision confidence, as measured by the number of points participants wagered on their predictions, varied with our definition of arbitration as a ratio of precisions. Functional neuroimaging demonstrated that arbitration signals were independent of decision confidence and involved modality-specific brain regions. Arbitrating in favor of self-gathered information activated the dorsolateral prefrontal cortex and the midbrain, whereas arbitrating in favor of social information engaged the ventromedial prefrontal cortex and the amygdala. These findings indicate that relative precision captures arbitration between social and individual learning systems at both behavioral and neural levels.
Collapse
Affiliation(s)
- Andreea Oliviana Diaconescu
- Translational Neuromodeling Unit, Institute for Biomedical Engineering, University of Zurich & ETH Zurich, Zurich, Switzerland.,Laboratory for Social and Neural Systems Research, Department of Economics, University of Zurich, Zurich, Switzerland.,University of Basel, Department of Psychiatry (UPK), Basel, Switzerland.,Krembil Centre for Neuroinformatics, Centre for Addiction and Mental Health (CAMH), University of Toronto, Toronto, Canada
| | - Madeline Stecy
- Translational Neuromodeling Unit, Institute for Biomedical Engineering, University of Zurich & ETH Zurich, Zurich, Switzerland.,Laboratory for Social and Neural Systems Research, Department of Economics, University of Zurich, Zurich, Switzerland.,Rutgers Robert Wood Johnson Medical School, New Brunswick, United States
| | - Lars Kasper
- Translational Neuromodeling Unit, Institute for Biomedical Engineering, University of Zurich & ETH Zurich, Zurich, Switzerland.,Laboratory for Social and Neural Systems Research, Department of Economics, University of Zurich, Zurich, Switzerland.,Institute for Biomedical Engineering, MRI Technology Group, ETH Zürich & University of Zurich, Zurich, Switzerland
| | - Christopher J Burke
- Laboratory for Social and Neural Systems Research, Department of Economics, University of Zurich, Zurich, Switzerland
| | - Zoltan Nagy
- Laboratory for Social and Neural Systems Research, Department of Economics, University of Zurich, Zurich, Switzerland
| | - Christoph Mathys
- Translational Neuromodeling Unit, Institute for Biomedical Engineering, University of Zurich & ETH Zurich, Zurich, Switzerland.,Interacting Minds Centre, Aarhus University, Aarhus, Denmark.,Scuola Internazionale Superiore di Studi Avanzati (SISSA), Trieste, Italy
| | - Philippe N Tobler
- Laboratory for Social and Neural Systems Research, Department of Economics, University of Zurich, Zurich, Switzerland
| |
Collapse
|
39
|
Abstract
OBJECTIVE Spiking activity of individual neurons can be separated from the acquired multi-unit activity with spike sorting methods. Processing the recorded high-dimensional neural data can take a large amount of time when performed on general-purpose computers. METHODS In this paper, an FPGA-based real-time spike sorting system is presented which takes into account the spatial correlation between the electrical signals recorded with closely-packed recording sites to cluster multi-channel neural data. The system uses a spatial window-based version of the Online Sorting algorithm, which uses unsupervised template-matching for clustering. RESULTS The test results show that the proposed system can reach an average accuracy of 86% using simulated data (16-32 neurons, 4-10 dB Signal-to-Noise Ratio), while the single-channel clustering version achieves only 74% average accuracy in the same cases on a 128-channel electrode array. The developed system was also tested on in vivo cortical recordings obtained from an anesthetized rat. CONCLUSION The proposed FPGA-based spike sorting system can process more than 11000 spikes/second, so it can be used during in vivo experiments providing real-time feedback on the location and electrophysiological properties of well-separable single units. SIGNIFICANCE The proposed spike sorting system could be used to reduce the positioning error of the closely-packed recording site during a neural measurement.
Collapse
|
40
|
Szentesi M, Nagy Z, Karoly Mangel Z, Csőre G, Géher P. AB0359 TNF ALFA THERAPY AND RADIOSYNOVIORTHESIS IN PATIENTS WITH RHEUMATOID ARTHRITIS. Ann Rheum Dis 2020. [DOI: 10.1136/annrheumdis-2020-eular.587] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
Background:The treatment of patients with rheumatoid arthritis (RA) has been spectaculary changed since the 1950’s. Introduction of the steroid compounds and their local application, the chemical and radionuclide synovectomy, surgical synovectomy, use of non steroid drugs, the basic treatment and the spread of biological therapy are the most important steps. Introduction of the biological therapy has changed the quality of life for these patients.Objectives:During biological therapy sometimes 1 or 2 joints could be affected by inflammation. In this cases always the question is how to solve the problem. Change of the biological or basic therapy, use surgical synovectomy or radiosynovectomy (RSO)?Methods:In our reumatological department 2100 patients with RA were treated with biological therapy between 2002 and 2018. In 100 patients we applied RSO because of the inflammation of the knee joint during biological therapy. We made a long term follow-up in 82 patient. All participants provided written informed consent. 82 participants inflammatory knee joint disease was diagnosed on the basis of the American College of Rheumatology. 70 of 82 patients with rheumatoid arthritis were seropositive, 12 seronegative. Steinbrocker functional stadium II was observed in 72, stadium III in 10. Mean age of 18 male and 76 female patients was 51.4 years (range 24-79) years. In 42 patients the right knee, in 40 the left knee was treated by radiosynovectomy. Mean duration of disease was 8.3 years (range 0.5-25), of synovitis (6.3month (range 3-8) Mean number of punctions of the treated joint prior to radiosynovectomy was 4,2 per patient and of steroid administrations prior to radiosynovectomy 3,0. In 15 patients a systemic steroid therapy has been performed.Results:During the study period, inflammation decreased. In the first 3 years excellent and good results were recorded in 81,2%. 3 years after radiosynoviorthesis 82.2% of patients did not need another punction.Before the knee inflammation patients were in complete remission which status has been achieved after RSO as well. DAS: 2,4+-0,4.Conclusion:1. RSO is an effective method to treat the inflammation of the knees.2. The RSO performed during biological tehrapy is as effective as in the case of patients without biological therapy.3. In case of a successful RSO there is no need for biological or basic therapy neither for surgical synovectomy.4. However an intraarticular injection has a low risk for infection it is recommended to avoid the biological therapy during the RSO.References:[1]WHO Scientific Group, 2003[2]Szekanecz Z.: Célzott terápia a reumatológiában. Klinikum és Tudomány, MOTESZ Magazin; 2010;XVIII(2):31–44.[3]McInnes IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol. 2007 Jun;7(6):429-42[4]Klippel JH. Primer on the Rheumatic Disease. 12th ed. 2001.[5]Lipsky PE. Harrison’s Principles of Internal Medicine. 16th ed. 2005[6]EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update[7]Fellinger K. and Schmid J.: Die lokale Behandlung der rheumatischen Erkrankungen. Z. Inn. Med. 33. 351. 1952.[8]Watanabe M., Takeda S., Ikeuchi H.: Atlas of arthroscopy 2nd ed. Tokyo: Igaku Shoin 1969.[9]Stucki G., Bozzone P., Treuer E., Wassmer P. and Felder M.: Efficacy and safety of radiation synovectomy with Yttrium-90: A retrospective long term analysis of 164 applications in 82 patients. British J. of Rheumatology 32. 5. 383-386. 1993.[10]Combe B., Krause E. and Sany J.: Treatment of chronic knee synovitis with arthroscopic synovectomy after failure of intra-articular injection of radionuclide. Arthritis Rheum. 32. 1. 10-14. 1989.Disclosure of Interests:None declared
Collapse
|
41
|
Pusztai A, Hamar A, Horváth Á, Végh E, Bodnár N, Kerekes G, Czókolyová M, Szamosi S, Bodoki L, Hodosi K, Domjan A, Nagy G, Szöllösi I, Lopez L, Matsuura E, Prohászka Z, Szántó S, Nagy Z, Shoenfeld Y, Szekanecz Z, Szücs G. THU0181 SOLUBLE VASCULAR BIOMARKERS IN RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS: EFFECTS OF ONE-YEAR ANTI-TNF-Α THERAPY. Ann Rheum Dis 2020. [DOI: 10.1136/annrheumdis-2020-eular.2481] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/15/2023]
Abstract
Background:Rheumatoid arthritis (RA) and ankylosing spondylitis (AS) have been associated with inflammatory atherosclerosis, increased cardiovascular (CV) morbidity and mortality. Numerous proteins may serve as biomarkers of inflammatory atherosclerosis. The treatment of arthritis by tumour necrosis factor α (TNF-α) inhibitors may decrease the serum concentrations of these biomarkers.Objectives:In this study we wished to determine circulating levels of oxidized LDL (oxLDL) - β2 glycoprotein I (β2GPI) complexes (AtherOx), anti-hsp60 antibodies, soluble urokinase plasminogen activator receptor (sUPAR) and N-terminal B-type natriuretic peptide (NT-proBNP) in sera of RA and AS patients. We also wished to assess the effects of anti-TNF treatment on these biomarkers.Methods:Altogether 53 arthritis patients including 36 RA patients treated with either etanercept (ETN) or certolizumab pegol (CZP) and 17 AS patients treated with ETN were included in a 12-month follow-up study.Circulating oxLDL/β2gpI complexes, anti-human Hsp60 immunoglobulin G (IgG) levels and BNP8-29fragment levels were assessed by ELISA. suPAR levels were assessed by suPARnostic®Quick Triage test. All laboratory assessments were performed at baseline, as well as 6 and 12 months after treatment initiation. Results were associated with DAS28, BASDAI, CRP.Results:In the mixed cohort of 53 arthritis patients, the circulating levels of oxLDL/β2gpI significantly decreased after 12 months of anti-TNF therapy (0.20±0.11 U/ml) compared to baseline (0.24±0.10 U/ml; p=0.014). There was a tendency of non-significant decrease after 6 months (0.23±0.14 U/ml) versus baseline. Anti-Hsp60 antibody levels did not change after 6 months (158.6±138.6 AU/ml) and 12 months (167.3±143.3 AU/ml) compared to baseline (170.3±140.4 AU/ml). Among the patients, 21.2% had low, 36.4% “observe”, 9.1% high and 33.3% critical suPAR levels. suPAR levels showed a tendency of non-significant decrease after 6 months (11.3±17.7 ng/ml) and 12 months (10.3±15.3 ng/ml) versus baseline (11.5±16.4 ng/ml). However, when the four serum level categories described above were considered, suPAR concentrations exerted significant decrease in RA patients with critical suPAR levels (>9ng/ml) (p=0.04). Similarly, BNP fragment levels showed only a tendency of decrease after 6 months (518.2±422.4 pmol/l) and 12 months (484.1±418.2 pmol/l) versus baseline (530.8±441.8 pmol/l). However, serum BNP levels at baseline and after 12 months were significantly increased in CCP positive compared to CCP negative RA patients (baseline: 670.6±323.0 versus 138.0±436.4 pmol/l; p=0.030 and 12 months: 652.9±283.2 versus 456.5±423.1 pmol/l; p=0.021), as well as in RF positive compared to RF negative RA patients (baseline: 680.6±381.6 versus 292.9±198.3 pmol/l; p=0.007 and 12 months: 668.9±346.5 versus 312.2±207.0 pmol/l; p=0.001).Conclusion:One-year anti-TNF therapy significantly decreased circulating oxLDL/β2gpI complex levels. This therapy also decreased suPAR levels in patients with critically high suPAR. BNP fragment levels were associated with seropositivity in RA. These vascular biomarkers may reflect the effects of TNF inhibition on endothelial activation.Acknowledgments:This study was sponsored by an investigator-initiated grant from Pfizer.Disclosure of Interests:Anita Pusztai: None declared, Attila Hamar: None declared, Ágnes Horváth: None declared, Edit Végh: None declared, Nóra Bodnár: None declared, György Kerekes: None declared, Monika Czókolyová: None declared, Szilvia Szamosi: None declared, Levente Bodoki: None declared, Katalin Hodosi: None declared, Andrea Domjan: None declared, Gábor Nagy: None declared, Ibolya Szöllösi: None declared, Luis Lopez Employee of: Retired employee of Corgenix Inc., Eiji Matsuura: None declared, Zoltán Prohászka: None declared, Sándor Szántó: None declared, Zoltán Nagy: None declared, Yehuda Shoenfeld: None declared, Zoltán Szekanecz Grant/research support from: Pfizer, UCB, Consultant of: Sanofi, MSD, Abbvie, Pfizer, Roche, Novertis, Lilly, Gedeon Richter, Amgen, Gabriella Szücs: None declared
Collapse
|
42
|
Haining EJ, Lowe KL, Wichaiyo S, Kataru RP, Nagy Z, Kavanagh DP, Lax S, Di Y, Nieswandt B, Ho-Tin-Noé B, Mehrara BJ, Senis YA, Rayes J, Watson SP. Lymphatic blood filling in CLEC-2-deficient mouse models. Platelets 2020; 32:352-367. [PMID: 32129691 PMCID: PMC8443399 DOI: 10.1080/09537104.2020.1734784] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
Abstract
C-type lectin-like receptor 2 (CLEC-2) is considered as a potential drug target in settings of wound healing, inflammation, and infection. A potential barrier to this is evidence that CLEC-2 and its ligand podoplanin play a critical role in preventing lymphatic vessel blood filling in mice throughout life. In this study, this aspect of CLEC-2/podoplanin function is investigated in more detail using new and established mouse models of CLEC-2 and podoplanin deficiency, and models of acute and chronic vascular remodeling. We report that CLEC-2 expression on platelets is not required to maintain a barrier between the blood and lymphatic systems in unchallenged mice, post-development. However, under certain conditions of chronic vascular remodeling, such as during tumorigenesis, deficiency in CLEC-2 can lead to lymphatic vessel blood filling. These data provide a new understanding of the function of CLEC-2 in adult mice and confirm the essential nature of CLEC-2-driven platelet activation in vascular developmental programs. This work expands our understanding of how lymphatic blood filling is prevented by CLEC-2-dependent platelet function and provides a context for the development of safe targeting strategies for CLEC-2 and podoplanin.
Collapse
Affiliation(s)
- Elizabeth J Haining
- Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
| | - Kate L Lowe
- Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
| | - Surasak Wichaiyo
- Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.,Department of Pharmacology, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand
| | - Raghu P Kataru
- Division of Plastic and Reconstructive Surgery, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - Zoltan Nagy
- Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
| | - Dean Pj Kavanagh
- Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
| | - Sian Lax
- Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
| | - Ying Di
- Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
| | - Bernhard Nieswandt
- Rudolf Virchow Center for Experimental Biomedicine and Institute of Experimental Biomedicine, University of Würzburg and University Hospital of Würzburg, Würzburg, Germany
| | - Benoît Ho-Tin-Noé
- Institut National de la Santé et de la Recherche Médicale, UMR_S1148, Université Paris Diderot, Sorbonne Paris Cité, Hôpital Bichat, Paris, France
| | - Babak J Mehrara
- Division of Plastic and Reconstructive Surgery, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - Yotis A Senis
- Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
| | - Julie Rayes
- Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.,Centre of Membrane Proteins and Receptors (COMPARE), Universities of Birmingham and Nottingham, The Midlands, UK
| | - Steve P Watson
- Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.,Centre of Membrane Proteins and Receptors (COMPARE), Universities of Birmingham and Nottingham, The Midlands, UK
| |
Collapse
|
43
|
Lee Y, Kettinger AO, Wilm BJ, Deichmann R, Weiskopf N, Lambert C, Pruessmann KP, Nagy Z. A comprehensive approach for correcting voxel-wise b-value errors in diffusion MRI. Magn Reson Med 2019; 83:2173-2184. [PMID: 31840300 PMCID: PMC7065087 DOI: 10.1002/mrm.28078] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2019] [Revised: 09/23/2019] [Accepted: 10/22/2019] [Indexed: 01/29/2023]
Abstract
PURPOSE In diffusion MRI, the actual b-value played out on the scanner may deviate from the nominal value due to magnetic field imperfections. A simple image-based correction method for this problem is presented. METHODS The apparent diffusion constant (ADC) of a water phantom was measured voxel-wise along 64 diffusion directions at b = 1000 s/mm2 . The true diffusion constant of water was estimated, considering the phantom temperature. A voxel-wise correction factor, providing an effective b-value including any magnetic field deviations, was determined for each diffusion direction by relating the measured ADC to the true diffusion constant. To test the method, the measured b-value map was used to calculate the corrected voxel-wise ADC for additionally acquired diffusion data sets on the same water phantom and data sets acquired on a small water phantom at three different positions. Diffusion tensor was estimated by applying the measured b-value map to phantom and in vivo data sets. RESULTS The b-value-corrected ADC maps of the phantom showed the expected spatial uniformity as well as a marked improvement in consistency across diffusion directions. The b-value correction for the brain data resulted in a 5.8% and 5.5% decrease in mean diffusivity and angular differences of the primary diffusion direction of 2.71° and 0.73° inside gray and white matter, respectively. CONCLUSION The actual b-value deviates significantly from its nominal setting, leading to a spatially variable error in the common diffusion outcome measures. The suggested method measures and corrects these artifacts.
Collapse
Affiliation(s)
- Yoojin Lee
- Laboratory for Social and Neural Systems Research (SNS Lab), University of Zurich, Zurich, Switzerland.,Institute for Biomedical Engineering, ETH Zurich and University of Zurich, Zurich, Switzerland
| | - Adam O Kettinger
- Brain Imaging Centre, Research Centre for Natural Sciences, Budapest, Hungary.,Department of Nuclear Techniques, Budapest University of Technology and Economics, Budapest, Hungary
| | - Bertram Jakob Wilm
- Institute for Biomedical Engineering, ETH Zurich and University of Zurich, Zurich, Switzerland
| | - Ralf Deichmann
- Brain Imaging Centre, Goethe University, Frankfurt, Germany.,Wellcome Centre for Human Neuroimaging, UCL Queen Square Institute of Neurology, London, United Kingdom
| | - Nikolaus Weiskopf
- Wellcome Centre for Human Neuroimaging, UCL Queen Square Institute of Neurology, London, United Kingdom.,Department of Neurophysics, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany
| | - Christian Lambert
- Wellcome Centre for Human Neuroimaging, UCL Queen Square Institute of Neurology, London, United Kingdom
| | - Klaas Paul Pruessmann
- Institute for Biomedical Engineering, ETH Zurich and University of Zurich, Zurich, Switzerland
| | - Zoltan Nagy
- Laboratory for Social and Neural Systems Research (SNS Lab), University of Zurich, Zurich, Switzerland.,Wellcome Centre for Human Neuroimaging, UCL Queen Square Institute of Neurology, London, United Kingdom
| |
Collapse
|
44
|
Jurczak W, Zinzani PL, Gaidano G, Goy A, Provencio M, Nagy Z, Robak T, Maddocks K, Buske C, Ambarkhane S, Winderlich M, Dirnberger-Hertweck M, Korolkiewicz R, Blum KA. Phase IIa study of the CD19 antibody MOR208 in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma. Ann Oncol 2019; 29:1266-1272. [PMID: 29444231 PMCID: PMC5961010 DOI: 10.1093/annonc/mdy056] [Citation(s) in RCA: 92] [Impact Index Per Article: 18.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022] Open
Abstract
Background This two-stage, phase IIa study investigated the antitumor activity and safety of MOR208, an Fc-engineered, humanized, CD19 antibody, in patients with relapsed or refractory (R-R) B-cell non-Hodgkin’s lymphoma (NHL). CD19 is broadly expressed across the B-lymphocyte lineage, including in B-cell malignancies, but not by hematological stem cells. Patients and methods Patients aged ≥18 years, with R-R NHL progressing after ≥1 prior rituximab-containing regimen were enrolled into subtype-specific cohorts: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), other indolent (i)NHL and mantle cell lymphoma (MCL). Treatment was MOR208, 12 mg/kg intravenously, weekly, for 8 weeks. Patients with at least stable disease could continue treatment for an additional 4 weeks. Those with a partial or complete response after 12 weeks could receive extended MOR208 treatment (12 mg/kg, either monthly or every second week) until progression. The primary end point was overall response rate. Results Ninety-two patients were enrolled: DLBCL (n = 35), FL (n = 34), other iNHL (n = 11) and MCL (n = 12). Responses were observed in DLBCL, FL and other iNHL cohorts (26%, 29% and 27%, respectively). They lasted ≥12 months in 5/9 responding patients with DLBCL, 4/9 with FL and 2/3 with other iNHL. Responses in nine patients are ongoing (>26 months in five instances). Patients with rituximab refractory disease showed a similar response rate and progression-free survival time to patients with non-refractory disease. The most common adverse events (any grade) were infusion-related reactions (12%) and neutropenia (12%). One patient experienced a grade 4 infusion-related reaction and eight patients (9%) experienced grade 3/4 neutropenia. No treatment-related deaths were reported. Conclusions MOR208 monotherapy demonstrated promising clinical activity in patients with R-R DLBCL and R-R FL, including in patients with rituximab refractory tumors. These efficacy data and the favorable safety profile support further investigation of MOR208 in phase II/III combination therapy trials in R-R DLBCL. ClinicalTrials.gov number NCT01685008.
Collapse
Affiliation(s)
- W Jurczak
- Department of Hematology, Jagiellonian University, Kraków, Poland.
| | - P L Zinzani
- Institute of Hematology "L. e A. Seràgnoli", University of Bologna, Bologna
| | - G Gaidano
- Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy
| | - A Goy
- John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, USA
| | - M Provencio
- Department of Medical Oncology, University Hospital Puerta De Hierro, Madrid, Spain
| | - Z Nagy
- First Department of Internal Medicine, Semmelweis University, Budapest, Hungary
| | - T Robak
- Department of Hematology, Medical University of Lodz and Copernicus Memorial Hospital, Lodz, Poland
| | - K Maddocks
- Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, USA
| | - C Buske
- Comprehensive Cancer Center Ulm, Institute of Experimental Cancer Research, University Hospital of Ulm, Ulm
| | | | | | | | | | - K A Blum
- Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, USA
| |
Collapse
|
45
|
Papp V, Iljicsov A, Rajda C, Magyari M, Koch‐Henriksen N, Petersen T, Jakab G, Deme I, Nagy F, Imre P, Lohner Z, Kovács K, Birkás AJ, Köves Á, Rum G, Nagy Z, Kerényi L, Vécsei L, Bencsik K, Jobbágy Z, Diószeghy P, Horváth L, Galántai G, Kasza J, Molnár G, Simó M, Sátori M, Rózsa C, Ács P, Berki T, Lovas G, Komoly S, Illes Z. A population‐based epidemiological study of neuromyelitis optica spectrum disorder in Hungary. Eur J Neurol 2019; 27:308-317. [DOI: 10.1111/ene.14079] [Citation(s) in RCA: 22] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2019] [Accepted: 08/21/2019] [Indexed: 11/27/2022]
|
46
|
Vögtle T, Sharma S, Mori J, Nagy Z, Semeniak D, Scandola C, Geer MJ, Smith CW, Lane J, Pollack S, Lassila R, Jouppila A, Barr AJ, Ogg DJ, Howard TD, McMiken HJ, Warwicker J, Geh C, Rowlinson R, Abbott WM, Eckly A, Schulze H, Wright GJ, Mazharian A, Fütterer K, Rajesh S, Douglas MR, Senis YA. Heparan sulfates are critical regulators of the inhibitory megakaryocyte-platelet receptor G6b-B. eLife 2019; 8:e46840. [PMID: 31436532 PMCID: PMC6742478 DOI: 10.7554/elife.46840] [Citation(s) in RCA: 31] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2019] [Accepted: 08/21/2019] [Indexed: 02/06/2023] Open
Abstract
The immunoreceptor tyrosine-based inhibition motif (ITIM)-containing receptor G6b-B is critical for platelet production and activation. Loss of G6b-B results in severe macrothrombocytopenia, myelofibrosis and aberrant platelet function in mice and humans. Using a combination of immunohistochemistry, affinity chromatography and proteomics, we identified the extracellular matrix heparan sulfate (HS) proteoglycan perlecan as a G6b-B binding partner. Subsequent in vitro biochemical studies and a cell-based genetic screen demonstrated that the interaction is specifically mediated by the HS chains of perlecan. Biophysical analysis revealed that heparin forms a high-affinity complex with G6b-B and mediates dimerization. Using platelets from humans and genetically modified mice, we demonstrate that binding of G6b-B to HS and multivalent heparin inhibits platelet and megakaryocyte function by inducing downstream signaling via the tyrosine phosphatases Shp1 and Shp2. Our findings provide novel insights into how G6b-B is regulated and contribute to our understanding of the interaction of megakaryocytes and platelets with glycans.
Collapse
Affiliation(s)
- Timo Vögtle
- Institute of Cardiovascular Sciences, College of Medical and Dental SciencesUniversity of BirminghamBirminghamUnited Kingdom
| | - Sumana Sharma
- Cell Surface Signalling LaboratoryWellcome Trust Sanger InstituteCambridgeUnited Kingdom
| | - Jun Mori
- Institute of Cardiovascular Sciences, College of Medical and Dental SciencesUniversity of BirminghamBirminghamUnited Kingdom
| | - Zoltan Nagy
- Institute of Cardiovascular Sciences, College of Medical and Dental SciencesUniversity of BirminghamBirminghamUnited Kingdom
| | - Daniela Semeniak
- Institute of Experimental BiomedicineUniversity Hospital WürzburgWürzburgGermany
| | - Cyril Scandola
- Université de Strasbourg, Institut National de la Santé et de la Recherche Médicale, Etablissement Français du Sang Grand Est, Unité Mixte de Recherche-S 1255, Fédération de Médecine Translationnelle de StrasbourgStrasbourgFrance
| | - Mitchell J Geer
- Institute of Cardiovascular Sciences, College of Medical and Dental SciencesUniversity of BirminghamBirminghamUnited Kingdom
| | - Christopher W Smith
- Institute of Cardiovascular Sciences, College of Medical and Dental SciencesUniversity of BirminghamBirminghamUnited Kingdom
| | - Jordan Lane
- Sygnature Discovery LimitedNottinghamUnited Kingdom
| | | | - Riitta Lassila
- Coagulation Disorders Unit, Department of Hematology, Comprehensive Cancer CenterUniversity of Helsinki, Helsinki University HospitalHelsinkiFinland
- Aplagon OyHelsinkiFinland
| | - Annukka Jouppila
- Coagulation Disorders UnitHelsinki University Hospital Research InstituteHelsinkiFinland
| | - Alastair J Barr
- Department of Biomedical Science, Faculty of Science & TechnologyUniversity of WestminsterLondonUnited Kingdom
| | - Derek J Ogg
- Peak Proteins LimitedAlderley ParkCheshireUnited Kingdom
| | - Tina D Howard
- Peak Proteins LimitedAlderley ParkCheshireUnited Kingdom
| | | | - Juli Warwicker
- Peak Proteins LimitedAlderley ParkCheshireUnited Kingdom
| | - Catherine Geh
- Peak Proteins LimitedAlderley ParkCheshireUnited Kingdom
| | | | - W Mark Abbott
- Peak Proteins LimitedAlderley ParkCheshireUnited Kingdom
| | - Anita Eckly
- Université de Strasbourg, Institut National de la Santé et de la Recherche Médicale, Etablissement Français du Sang Grand Est, Unité Mixte de Recherche-S 1255, Fédération de Médecine Translationnelle de StrasbourgStrasbourgFrance
| | - Harald Schulze
- Institute of Experimental BiomedicineUniversity Hospital WürzburgWürzburgGermany
| | - Gavin J Wright
- Cell Surface Signalling LaboratoryWellcome Trust Sanger InstituteCambridgeUnited Kingdom
| | - Alexandra Mazharian
- Institute of Cardiovascular Sciences, College of Medical and Dental SciencesUniversity of BirminghamBirminghamUnited Kingdom
| | - Klaus Fütterer
- School of Biosciences, College of Life and Environmental SciencesUniversity of BirminghamBirminghamUnited Kingdom
| | - Sundaresan Rajesh
- Institute of Cancer and Genomic Sciences, College of Medical and Dental SciencesUniversity of BirminghamBirminghamUnited Kingdom
| | - Michael R Douglas
- Institute of Inflammation and Ageing, College of Medical and Dental SciencesUniversity of BirminghamBirminghamUnited Kingdom
- Department of NeurologyDudley Group NHS Foundation TrustDudleyUnited Kingdom
- School of Life and Health SciencesAston UniversityBirminghamUnited Kingdom
| | - Yotis A Senis
- Institute of Cardiovascular Sciences, College of Medical and Dental SciencesUniversity of BirminghamBirminghamUnited Kingdom
- Université de Strasbourg, Institut National de la Santé et de la Recherche Médicale, Etablissement Français du Sang Grand Est, Unité Mixte de Recherche-S 1255, Fédération de Médecine Translationnelle de StrasbourgStrasbourgFrance
| |
Collapse
|
47
|
Salles G, Duell J, González Barca E, Jurczak W, Liberati A, Nagy Z, Obr A, Gaidano G, Andre M, Kalakonda N, Dreyling M, Zinzani P, Dirnberger-Hertweck M, Weirather J, Ambarkhane S, Maddocks K. PRIMARY ANALYSIS RESULTS OF THE SINGLE-ARM PHASE II STUDY OF MOR208 PLUS LENALIDOMIDE IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (L-MIND). Hematol Oncol 2019. [DOI: 10.1002/hon.130_2629] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- G. Salles
- Hospices Civils de Lyon; Centre Hospitalier Lyon Sud, Service d'Hématologie; Pierre-Bénite France
| | - J. Duell
- Medizinische Klinik und Poliklinik II; University Hospital of Würzburg; Würzburg Germany
| | - E. González Barca
- Department of Hematology; Institut Catalá d'Oncología, Hospital Duran i Reynals, IDIBELL; Barcelona Spain
| | - W. Jurczak
- Department of Hematology; Jagiellonian University; Kraków Poland
| | - A.M. Liberati
- SC Oncoematologia; Azienda Ospedaliera Santa Maria; Terni Italy
| | - Z. Nagy
- First Department of Internal Medicine; Semmelweis University; Budapest Hungary
| | - A. Obr
- Department of Hemato-Oncology; Palacký University Olomouc and the University Hospital Olomouc; Olomouc Czech Republic
| | - G. Gaidano
- Division of Haematology; Department of Translational Medicine, University of Eastern Piedmont; Novara Italy
| | - M. Andre
- Department of Hematology; Université catholique de Louvain, CHU UCL Namur; Yvoir Belgium
| | - N. Kalakonda
- Department of Haemato-oncology; Clatterbridge Cancer Centre and University of Liverpool; Wirral United Kingdom
| | - M. Dreyling
- Department of Medicine III; University Hospital of Ludwig-Maximilians-Universität; Munich Germany
| | - P.L. Zinzani
- Institute of Hematology “L. e A. Seràgnoli”; University of Bologna; Bologna Italy
| | | | - J. Weirather
- Department of Biostatistics and Data Management; MorphoSys AG; Planneg Germany
| | - S. Ambarkhane
- Department of Clinical Development; MorphoSys AG; Planegg Germany
| | - K. Maddocks
- Department of Internal Medicine; Division of Hematology, The Ohio State University Comprehensive Cancer Center; Columbus Ohio United States
| |
Collapse
|
48
|
Röth A, Nagy Z, Peffault de Latour R, Ninomya H, Panse J, Yoon S, Egyed M, Ichikawa S, Ito Y, Seok Kim J, Schrezenmeier H, Sica S, Usuki K, Sostelly A, Higginson J, Dieckmann A, Anzures-Cabreras J, Shinomiya K, Klughammer B, Jahreis A, Bucher C, Nishimura J. PF348 LONG TERM FOLLOW-UP OF PNH PATIENTS TREATED WITH THE SMART ANTI-HC5 ANTIBODY (SKY59/RO7112689) IN THE OPEN LABEL EXTENSION (OLE) OF THE COMPOSER TRIAL. Hemasphere 2019. [DOI: 10.1097/01.hs9.0000559604.06488.14] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
49
|
Polania R, Moisa M, Grueschow M, Nagy Z, Lee Y, Ruff C. Causal account of brain network computations driving value-based decisions. Brain Stimul 2019. [DOI: 10.1016/j.brs.2018.12.612] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
50
|
Flinn IW, Miller CB, Ardeshna KM, Tetreault S, Assouline SE, Mayer J, Merli M, Lunin SD, Pettitt AR, Nagy Z, Tournilhac O, Abou-Nassar KE, Crump M, Jacobsen ED, de Vos S, Kelly VM, Shi W, Steelman L, Le N, Weaver DT, Lustgarten S, Wagner-Johnston ND, Zinzani PL. DYNAMO: A Phase II Study of Duvelisib (IPI-145) in Patients With Refractory Indolent Non-Hodgkin Lymphoma. J Clin Oncol 2019; 37:912-922. [PMID: 30742566 DOI: 10.1200/jco.18.00915] [Citation(s) in RCA: 144] [Impact Index Per Article: 28.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022] Open
Abstract
PURPOSE Indolent non-Hodgkin lymphoma (iNHL) remains largely incurable and often requires multiple lines of treatment after becoming refractory to standard therapies. Duvelisib was approved by the Food and Drug Administration for relapsed or refractory (RR) chronic lymphocytic leukemia or small lymphocytic lymphoma (SLL) and RR follicular lymphoma (FL) after two or more prior systemic therapies. On the basis of the activity of duvelisib, a first-in-class oral dual inhibitor of phosphoinositide 3-kinase-δ,-γ, in RR iNHL in a phase I study, the safety and efficacy of duvelisib monotherapy was evaluated in iNHL refractory to rituximab and either chemotherapy or radioimmunotherapy. PATIENTS AND METHODS Eligible patients had measurable iNHL (FL, SLL, or marginal zone B-cell lymphoma) double refractory to rituximab (monotherapy or in combination) and to either chemotherapy or radioimmunotherapy. All were treated with duvelisib 25 mg orally twice daily in 28-day cycles until progression, unacceptable toxicity, or death. The primary end point was overall response rate (ORR) using the revised International Working Group criteria for malignant lymphoma. RESULTS This open-label, global phase II trial enrolled 129 patients (median age, 65 years; median of three prior lines of therapy) with an ORR of 47.3% (SLL, 67.9%; FL, 42.2%; MZL, 38.9%). The estimated median duration of response was 10 months, and the estimated median progression-free survival was 9.5 months. The most frequent any-grade treatment-emergent adverse events (TEAEs) were diarrhea (48.8%), nausea (29.5%), neutropenia (28.7%), fatigue (27.9%), and cough (27.1%). Among the 88.4% of patients with at least one grade 3 or greater TEAE, the most common TEAEs were neutropenia (24.8%), diarrhea (14.7%), anemia (14.7%), and thrombocytopenia (11.6%). CONCLUSION In the DYNAMO study, oral duvelisib monotherapy demonstrated clinically meaningful activity and a manageable safety profile in heavily pretreated, double-refractory iNHL, consistent with previous observations. Duvelisib may provide a new oral treatment option for this patient population of which many are elderly and in need of additional therapies.
Collapse
Affiliation(s)
- Ian W Flinn
- 1 Sarah Cannon Research Institute, Nashville, TN.,2 Tennessee Oncology, Nashville, TN
| | - Carole B Miller
- 3 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD
| | - Kirit M Ardeshna
- 4 University College London Hospitals National Health Service Foundation Trust, London, United Kingdom
| | | | | | - Jiri Mayer
- 7 Fakultní Nemocnice Brno, Brno, Czech Republic
| | - Michele Merli
- 8 Ospedale di Circolo e Fondazione Macchi, Varese, Italy
| | | | | | | | | | | | - Michael Crump
- 13 Princess Margaret Cancer Centre, Toronto, Ontario, Canada
| | | | - Sven de Vos
- 15 Ronald Reagan University of California, Los Angeles, Medical Center, Los Angeles, CA
| | | | | | | | | | | | | | | | | |
Collapse
|